hg_132802.1

Basic information about the TSS

---

TSS ID: hg_132802.1 Species: human Chr: chr12		Start: 96400489 End: 96400503 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK315214 Distance: 0 GeneID: 5128 HGNC/MGI_ID: HGNC:8750 UniProt_ID:

Gene_name: cyclin dependent kinase 17 Gene_symbol: CDK17 Gene_synonyms: PCTAIRE2 Gene_source: HGNC:8750

TATA-Box annotation

---

Distance to TSS:	-57
Nearest PromoterID:	NM_001170464
Entrez ID:	5128
Nearest Unigene:	Hs.506415
Nearest Refseq:	NM_002595
Nearest Ensembl:	ENSG00000059758
Gene Name:	cyclin dependent kinase 17
Gene Alias:	PCTAIRE2|PCTK2
Gene Description:	cyclin dependent kinase 17
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.661692
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDK17 p3@CDK17 p4@CDK17 p5@CDK17 p6@CDK17 p7@CDK17 p8@CDK17 p9@CDK17 p10@CDK17
Sample		p1@CDK17	p3@CDK17	p4@CDK17	p5@CDK17	p6@CDK17	p7@CDK17	p8@CDK17	p9@CDK17	p10@CDK17
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.81	1.36	0.78	0.78	0.78	0.00	0.00	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.60	1.01	0.40	1.21	0.81	0.20	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.73	0.77	0.96	1.54	0.19	0.19	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.22	0.83	0.00	0.83	1.04	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.70	1.12	0.90	2.02	1.57	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.09	1.74	0.39	1.16	0.39	0.39	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.89	0.87	0.65	1.09	0.87	0.00	0.22	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.66	2.18	1.45	0.48	0.48	0.00	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.90	1.07	0.43	0.64	0.21	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	2.90	6.38	3.48	3.48	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.02	0.81	1.62	1.21	1.62	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	25.61	2.44	1.63	0.41	3.66	0.00	0.00	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.74	3.39	0.00	1.13	0.00	0.00	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.26	1.50	0.00	0.30	0.00	0.00	0.00	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.15	1.76	0.44	0.22	0.00	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.28	1.51	0.00	1.26	0.00	0.25	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.21	1.31	0.22	0.22	0.22	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	0.42	0.00	0.42	0.00	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	3.20	0.00	0.53	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.17	1.96	0.30	0.45	0.00	0.30	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.22	3.21	0.53	0.40	0.13	0.00	0.27	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.60	2.24	0.17	0.17	0.00	0.52	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.27	1.42	0.13	0.39	0.00	0.13	0.26	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.77	0.49	0.49	0.24	1.21	0.49	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.55	1.29	0.52	0.77	0.26	0.77	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	2.53	0.32	1.58	0.00	1.58	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	1.10	0.55	0.00	0.55	0.55	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.49	1.65	0.71	0.94	0.47	0.24	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.60	2.10	0.48	1.45	0.81	1.13	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.49	2.53	0.00	0.72	1.09	0.72	0.36	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	3.35	1.05	1.05	0.42	0.00	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.50	1.76	0.39	1.95	0.98	0.39	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.93	1.90	0.84	0.84	0.63	0.42	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.35	2.47	0.33	1.32	1.15	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.41	3.18	0.75	2.24	1.12	0.19	0.19	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.86	3.26	0.38	0.96	0.96	0.57	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.85	2.66	1.02	1.02	1.84	0.20	0.00	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.69	2.42	0.81	1.01	0.40	0.20	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	2.16	0.81	2.43	1.35	0.54	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.32	3.60	0.48	0.48	0.72	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.06	1.41	0.71	0.71	0.94	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.39	1.90	1.17	1.61	0.73	0.29	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	1.90	0.63	0.21	0.21	0.21	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.87	2.45	0.52	0.17	0.52	0.17	0.70	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.83	3.21	0.80	0.40	0.80	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.98	3.72	0.23	0.23	0.70	0.23	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.40	2.40	0.24	0.96	0.72	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	2.09	1.79	1.79	0.60	0.00	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.53	3.11	0.00	0.72	1.44	0.00	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.92	4.65	0.61	1.62	0.61	0.00	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.04	4.10	0.61	1.23	0.82	0.00	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.89	2.89	0.67	0.89	0.67	0.00	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	3.55	0.71	1.06	0.35	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.28	1.66	0.66	0.33	0.33	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	2.52	0.00	1.68	0.84	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	2.30	0.00	0.92	0.46	0.00	0.92	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.10	2.92	0.65	0.65	0.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	2.57	0.32	0.00	0.64	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.03	1.26	0.00	0.31	0.00	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	1.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	1.12	1.12	0.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	2.39	0.80	1.59	0.00	0.00	1.59	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.46	3.40	0.34	0.34	0.34	0.00	0.34	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.15	4.87	0.32	1.95	0.32	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.61	1.42	0.35	0.35	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	2.44	0.49	0.00	0.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.45	2.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	0.94	0.47	0.94	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	1.99	0.00	0.00	0.33	0.00	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.81	2.17	0.31	0.31	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.73	2.45	0.00	1.22	0.31	0.00	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	5.70	1.27	0.00	0.48	0.00	0.16	0.32	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	4.49	1.28	0.16	0.16	0.16	0.00	0.00	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	5.73	1.65	0.25	0.76	0.13	0.13	0.13	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	3.74	0.75	0.00	1.49	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	2.01	1.00	0.33	0.33	0.00	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	4.47	0.64	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	1.35	0.90	0.90	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.17	0.17	0.00	0.17	0.00	0.00	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	15.65	3.32	0.39	0.00	0.00	0.20	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	6.43	0.77	0.77	0.77	0.26	0.26	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	12.27	2.79	0.56	0.84	0.56	0.28	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	1.76	0.00	1.18	0.59	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	5.79	1.37	0.32	0.24	0.32	0.00	0.16	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	6.13	1.29	0.00	0.00	0.00	0.00	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	1.07	0.00	1.07	0.53	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	2.78	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	5.41	0.42	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	5.78	0.25	0.00	0.00	0.00	0.00	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	5.24	1.64	0.65	0.33	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	5.75	0.88	0.44	0.44	0.00	0.00	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.32	1.62	0.00	0.36	0.18	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.11	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	13.85	2.40	0.92	2.06	1.26	0.57	0.23	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.84	1.22	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	38.19	1.35	0.90	2.70	0.45	2.70	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.94	2.60	0.43	3.47	0.00	3.91	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	40.66	6.42	0.00	8.56	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.66	4.48	1.79	2.99	0.30	1.79	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	5.06	1.26	1.26	1.26	5.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	33.66	3.96	0.66	3.96	0.66	2.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	36.06	3.57	0.97	3.25	0.32	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	35.92	4.37	0.97	1.46	0.97	2.91	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	1.19	2.38	1.78	0.59	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	37.66	2.64	3.39	2.26	1.51	1.13	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.11	2.90	0.00	2.18	1.45	2.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	3.76	2.51	6.27	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	48.93	3.79	2.47	4.28	1.48	3.13	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	32.76	2.73	2.73	1.36	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.78	3.92	2.41	4.07	1.21	2.11	0.00	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.83	1.07	1.07	2.68	0.00	3.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.28	0.94	1.70	1.89	1.51	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	37.15	2.67	2.14	3.21	0.53	1.34	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	4.88	3.90	3.90	0.00	0.98	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.18	1.99	1.00	2.16	1.00	2.49	0.00	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	2.40	0.00	1.20	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.16	2.40	1.54	2.06	0.69	1.89	0.00	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	4.19	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	32.04	4.37	0.49	1.94	0.97	1.46	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	34.91	2.66	0.76	1.14	0.38	3.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	4.85	3.63	4.85	1.21	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	33.06	5.13	0.57	1.71	0.00	0.57	0.57	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	34.63	2.57	0.43	2.78	0.64	2.99	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.00	2.58	1.29	5.16	1.29	1.81	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.03	3.75	0.47	1.88	0.47	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.41	4.18	2.25	3.86	0.96	1.93	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	2.14	0.71	4.99	0.71	2.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	29.25	5.26	3.51	0.58	0.00	1.75	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	38.84	6.02	1.51	4.22	1.51	2.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	35.64	0.00	0.00	7.13	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	40.68	2.03	1.02	2.03	0.51	2.54	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	38.46	3.31	3.31	3.06	2.80	3.57	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.23	3.18	1.91	3.18	2.54	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.11	2.16	0.43	4.32	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.60	1.69	1.27	3.39	1.48	2.33	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.68	2.32	1.45	3.48	0.58	1.16	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	37.79	5.67	1.89	2.83	0.94	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	33.23	2.88	1.53	2.03	1.02	2.88	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	2.32	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	6.34	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.44	2.57	1.29	2.79	1.50	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	27.68	3.01	2.41	3.01	0.60	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.14	0.00	0.73	2.92	0.73	2.92	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.79	1.38	2.07	1.61	1.15	2.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	0.00	0.00	7.65	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.75	3.81	1.78	4.32	2.54	2.29	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.65	2.89	1.24	2.68	0.21	1.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	38.25	2.75	0.61	7.04	0.00	1.84	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	40.63	2.87	1.91	2.87	0.48	2.87	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	31.04	3.99	2.00	2.88	0.89	2.22	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	36.62	1.53	7.63	6.10	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	38.22	4.43	1.11	1.66	1.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	33.89	2.65	1.85	3.71	0.53	1.85	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.98	2.54	1.82	6.54	0.36	1.45	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	7.98	1.35	0.37	0.12	0.12	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	5.99	1.03	0.00	0.00	0.34	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.66	2.10	0.00	0.21	0.21	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	19.17	3.14	1.39	1.05	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.41	2.75	0.81	1.46	0.16	0.00	0.16	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	16.71	1.34	1.04	0.75	0.15	0.00	0.15	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	16.63	3.21	0.57	2.98	0.34	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13.03	3.88	1.50	2.38	0.13	0.13	0.00	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	12.52	3.53	0.34	2.28	0.34	0.11	0.23	0.11	0.11
Basophils, donor1	12241-129G9	91.27	6.54	19.35	2.35	12.03	0.26	1.57	1.83	0.52
Basophils, donor2	12242-129H1	109.32	3.61	67.11	2.89	41.85	0.00	0.00	0.72	3.25
Basophils, donor3	12243-129H2	51.16	2.20	15.88	0.73	8.97	0.15	0.00	0.44	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	2.80	0.43	0.22	0.00	0.00	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	1.37	0.00	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	0.00	0.63	0.00	1.26	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.65	1.87	0.21	0.62	0.21	0.00	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	11.74	1.61	0.23	0.69	0.46	0.46	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	4.68	1.62	0.18	0.36	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.92	3.61	1.44	1.44	0.62	0.10	0.72	0.93	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.55	1.86	1.86	1.40	0.47	0.00	0.47	0.70	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	47.97	3.20	1.92	1.92	0.64	0.00	0.32	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	63.12	2.82	9.02	0.00	2.82	0.56	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	49.74	2.41	9.09	1.11	5.01	0.19	0.00	0.93	0.56
CD14+ Monocytes, donor3	11381-118B4	55.32	1.76	10.76	0.88	5.05	0.44	0.44	0.88	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	10.19	4.25	0.28	0.57	0.85	0.00	0.85	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	12.51	3.41	1.90	0.76	1.52	0.00	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	8.55	2.63	0.66	0.99	0.33	0.00	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.83	4.34	1.45	1.30	0.58	0.00	0.43	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	13.28	3.32	1.81	1.81	1.21	0.00	0.30	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	11.84	4.74	1.66	0.95	0.00	0.00	0.47	0.71	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.37	1.51	1.34	1.17	1.00	0.33	0.00	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.97	3.04	0.83	1.66	0.55	0.00	0.28	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.39	1.49	1.74	0.99	0.50	0.00	0.00	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	16.06	3.33	1.17	4.50	0.98	0.98	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.79	4.81	0.89	5.88	2.14	0.53	0.53	0.89	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.33	4.57	1.96	3.05	1.31	0.87	0.22	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	2.81	1.87	2.81	1.40	0.70	0.23	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.42	3.70	1.58	1.58	3.17	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	3.33	2.22	4.44	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.30	3.57	1.49	0.59	0.59	0.15	0.45	0.45	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.98	3.39	0.80	0.80	1.20	0.00	0.80	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.45	7.70	1.25	2.29	1.46	0.00	0.62	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.41	3.20	0.92	1.37	0.69	0.46	0.69	0.23	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	23.30	4.98	1.13	1.36	1.81	0.00	0.68	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.09	3.06	0.87	3.93	1.75	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	19.10	4.30	0.81	2.69	0.81	0.27	0.00	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.56	6.28	1.22	5.06	1.92	0.52	0.35	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.56	7.57	1.68	6.73	1.68	0.00	1.26	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.02	3.12	2.02	1.84	1.65	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.85	3.87	1.06	1.76	3.52	1.06	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	16.67	6.14	0.44	2.63	0.88	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.91	5.41	1.05	2.79	1.92	2.09	0.70	0.70	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	20.07	4.09	0.37	5.95	1.12	1.86	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.30	6.25	1.94	2.16	1.72	1.08	0.00	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.47	3.28	1.23	0.82	2.05	0.82	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.76	4.64	1.39	2.09	1.62	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.27	4.18	1.86	2.55	2.32	0.46	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	9.37	2.83	1.09	1.09	0.44	0.22	0.00	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	12.47	2.08	0.46	0.23	0.46	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.35	2.82	0.43	0.00	0.22	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	12.46	3.11	0.00	0.78	0.31	0.00	0.00	0.47	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	11.00	2.45	0.52	0.52	0.35	0.00	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	11.37	1.78	0.22	1.11	0.22	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	20.67	3.06	1.28	0.77	0.26	0.00	0.51	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	19.54	3.73	1.10	1.32	0.22	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	16.00	4.00	1.26	0.63	0.42	0.00	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	16.26	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	6.78	2.03	3.39	0.00	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	8.28	1.04	1.04	0.00	0.00	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	32.52	6.40	0.53	3.73	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.09	6.97	1.61	2.68	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	32.29	7.72	0.70	2.11	0.00	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.88	7.84	0.00	3.14	0.00	0.00	0.78	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	6.59	0.00	7.91	1.32	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	73.15	0.00	5.75	0.82	1.64	0.00	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	105.91	3.63	6.53	1.45	5.08	0.00	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	81.78	6.06	10.10	3.03	2.02	0.50	1.51	0.00	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	36.37	6.87	0.40	3.23	0.00	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	30.76	8.79	0.00	2.80	0.00	1.60	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	132.53	7.03	10.04	1.00	6.02	0.00	2.01	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	180.90	3.93	19.10	0.00	12.92	0.00	0.56	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.18	3.76	1.13	0.75	0.75	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.71	4.06	0.90	2.03	0.68	0.00	0.45	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	229.59	1.43	23.92	3.57	3.57	0.71	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	261.48	2.45	36.13	4.29	17.76	0.61	1.22	3.06	0.61
CD4+ T Cells, donor3	11382-118B5	214.11	6.40	25.31	4.27	12.20	2.13	0.91	0.91	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.40	5.62	0.26	0.51	0.26	0.00	0.51	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	16.17	5.39	0.90	1.57	0.67	0.00	0.22	0.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.00	7.76	0.57	2.59	0.00	0.00	0.29	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	148.39	4.74	5.69	6.16	2.37	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	142.57	12.64	7.02	4.21	0.00	0.00	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	148.33	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.85	4.77	1.73	1.01	0.58	0.00	0.43	0.43	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.95	2.37	0.68	1.53	0.00	0.17	0.68	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.99	4.35	1.29	1.29	0.48	0.32	0.00	0.97	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	88.31	3.59	2.69	1.34	0.45	0.45	0.45	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	60.09	6.29	1.40	2.10	0.35	0.00	0.35	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	54.56	3.96	2.20	2.64	0.00	0.00	0.44	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.46	5.90	1.69	0.42	0.42	0.00	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.89	3.74	1.25	1.45	1.25	0.00	0.83	0.42	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.39	4.34	3.01	0.67	1.34	0.00	0.33	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	149.02	5.71	8.70	4.35	1.63	0.00	1.09	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	151.67	4.82	8.58	2.68	2.14	0.00	0.00	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	157.80	7.17	3.59	3.59	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.22	4.64	2.41	1.11	0.74	0.00	0.56	0.37	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	33.14	3.47	7.15	1.52	2.17	0.00	0.43	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.33	3.57	9.88	1.89	4.20	0.00	0.84	0.63	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	143.09	5.06	22.75	2.53	9.61	1.01	0.51	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	133.01	4.77	17.33	1.30	2.17	0.43	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	120.72	6.54	8.72	1.74	3.05	1.31	2.18	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	102.44	4.45	6.43	7.92	1.98	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.01	5.54	15.69	0.92	4.62	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	104.69	6.98	15.35	6.98	4.19	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	106.62	7.20	9.42	1.38	3.32	0.00	0.83	0.28	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	104.54	7.36	7.12	0.49	2.21	0.25	0.74	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	106.26	12.32	18.48	0.00	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	101.35	8.24	13.97	3.22	7.52	0.00	0.36	0.72	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	123.26	4.15	12.46	8.31	6.92	0.00	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	261.92	4.58	97.24	3.27	62.86	0.65	1.96	1.31	1.64
CD8+ T Cells, donor2	11307-117C2	233.52	2.25	96.11	4.51	52.94	2.25	1.88	1.88	1.88
CD8+ T Cells, donor3	11383-118B6	239.61	3.03	64.64	2.02	33.83	1.01	1.51	1.26	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.14	1.61	0.23	0.46	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.14	1.92	0.96	1.20	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.24	1.64	0.55	1.37	0.55	0.00	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.21	2.70	0.30	2.10	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.72	2.16	0.00	1.44	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.83	1.59	0.91	1.59	0.23	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.30	1.52	0.43	1.30	0.22	0.00	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.53	1.05	1.58	1.05	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.82	1.64	1.17	1.41	0.23	0.23	0.00	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.32	1.51	0.91	0.60	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	21.79	1.74	0.29	1.45	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	24.25	1.87	0.80	0.80	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.46	3.50	1.75	0.88	0.88	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	39.17	4.55	1.37	2.28	1.37	0.46	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	36.55	2.24	1.49	0.00	0.75	0.00	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	18.37	1.44	1.44	0.36	0.00	0.00	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.84	3.16	0.29	1.44	0.00	0.00	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.50	1.65	0.94	1.41	0.24	0.00	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.21	1.90	0.63	0.63	0.32	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.84	3.08	0.92	1.23	0.31	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.43	3.21	0.96	1.28	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	2.68	1.91	0.76	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.41	1.58	1.18	1.58	1.18	0.00	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.04	0.76	1.51	1.51	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	67.45	8.03	1.61	4.82	1.61	0.00	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	61.55	5.60	2.80	8.39	0.70	0.70	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	70.12	3.01	3.01	0.00	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	23.76	0.00	0.00	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	0.99	0.00	0.49	0.00	0.00	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	9.68	1.16	0.11	0.32	0.00	0.00	0.11	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	10.75	0.69	1.04	0.00	0.69	0.69	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.04	0.71	0.00	0.00	0.36	0.00	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	7.62	1.71	0.57	0.23	0.57	0.34	0.23	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	9.85	0.90	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.92	3.64	1.62	0.40	0.40	0.00	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	23.64	2.18	1.26	1.26	1.15	0.00	0.23	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	19.24	2.57	1.92	1.07	1.07	0.00	0.00	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	17.17	2.30	0.97	0.62	0.53	0.09	0.09	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.13	3.12	1.74	2.57	1.10	0.28	0.28	0.46	0.37
Corneal Epithelial Cells, donor1	11526-119I5	3.29	1.32	0.22	0.00	0.00	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.07	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.57	2.81	0.50	0.50	0.00	0.00	0.50	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.20	1.58	0.63	0.00	0.00	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.99	1.51	0.76	0.76	0.11	0.00	0.11	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	57.40	3.42	15.03	2.73	7.86	0.00	0.00	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	60.06	3.26	11.75	4.57	1.96	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	85.66	4.84	8.71	0.48	9.19	0.00	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	47.86	4.50	0.83	6.67	1.17	3.67	1.67	0.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	38.73	7.63	0.59	4.11	0.00	1.76	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	46.94	4.24	0.57	3.96	0.57	1.70	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	69.99	7.47	1.97	5.50	1.57	4.72	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	31.71	2.33	0.00	4.07	0.29	0.87	0.29	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	42.82	5.65	1.41	4.47	0.24	2.59	1.41	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	56.27	8.77	0.88	4.91	0.35	3.33	0.35	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.32	5.54	0.66	7.31	0.89	3.99	0.44	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.16	6.09	2.43	5.48	0.30	3.04	0.91	0.91	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	59.20	6.48	2.26	5.36	0.85	4.23	1.41	2.26	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	34.76	4.75	0.30	1.19	0.00	0.30	1.19	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	1.04	0.52	2.60	0.52	0.00	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	27.93	3.83	0.57	2.69	0.28	0.71	0.43	1.56	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	49.21	4.80	0.80	1.60	0.80	2.00	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	33.02	3.14	0.52	1.57	0.00	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.06	8.08	0.99	9.44	1.62	3.11	0.87	1.74	2.73
Endothelial Cells - Umbilical vein, donor2	11324-117E1	32.37	4.56	0.87	4.13	0.65	1.30	0.22	1.30	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	48.73	6.35	0.73	6.11	1.59	3.79	0.73	1.34	1.47
Endothelial Cells - Vein, donor1	11267-116G7	70.53	3.41	1.14	3.41	1.14	5.69	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	55.18	6.29	2.10	2.79	0.00	3.49	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	59.66	5.65	2.04	8.48	1.26	5.02	0.47	0.16	0.63
Eosinophils, donor1	12244-129H3	137.22	15.25	167.72	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	150.17	19.80	11.55	4.95	14.85	0.00	3.30	1.65	1.65
Eosinophils, donor3	12246-129H5	96.30	7.13	14.27	3.57	7.13	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.90	1.23	0.00	0.41	0.41	0.41	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.13	0.77	0.33	0.11	0.33	0.00	0.11	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.97	1.19	0.33	0.98	0.65	0.22	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.13	1.94	0.61	2.43	0.49	0.12	0.12	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.94	4.09	3.00	2.18	1.77	1.09	0.00	0.68	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	1.79	0.32	1.05	0.21	0.11	0.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.25	5.53	0.53	1.05	0.53	1.84	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.62	2.99	1.33	1.99	0.66	0.00	0.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	12.25	0.00	0.91	0.45	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	27.29	5.31	0.00	0.76	0.00	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	10.25	1.89	0.63	1.10	0.16	0.16	0.32	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	16.67	1.21	0.00	0.61	0.30	0.00	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	37.94	3.93	0.63	2.28	0.51	1.90	0.00	0.13	0.38
Fibroblast - Cardiac, donor6	11460-119B2	25.47	4.09	0.30	1.36	0.76	1.36	0.15	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.45	1.07	0.00	0.00	0.27	0.00	0.13	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.41	0.86	0.86	0.86	0.00	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	1.46	0.00	0.00	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.30	2.31	0.23	1.61	0.23	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.43	1.70	0.00	0.68	0.17	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	15.50	3.29	0.23	0.94	0.94	0.00	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	16.04	2.83	0.94	1.42	0.47	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	19.70	2.42	1.33	1.69	0.73	0.48	0.24	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	18.43	3.84	0.11	1.24	0.23	0.11	0.00	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	16.40	3.66	0.70	1.57	0.52	0.35	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	14.13	2.92	0.32	0.97	0.16	0.65	0.16	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	7.70	1.87	0.42	1.25	0.21	0.62	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.38	3.93	0.00	1.57	0.26	0.00	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	5.67	1.58	0.00	1.58	0.00	0.00	0.00	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	7.44	3.09	0.39	0.58	0.29	0.10	0.10	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	4.16	1.04	3.12	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.22	3.35	0.88	2.29	0.18	0.18	0.18	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	11.07	2.03	0.31	0.78	0.47	0.47	0.00	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.52	4.73	0.14	1.89	0.41	0.14	0.14	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	35.99	8.12	0.00	3.53	1.06	0.71	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.11	3.07	0.58	2.49	0.44	0.58	0.00	0.15	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	7.09	2.32	0.14	1.23	0.00	0.41	0.27	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.04	3.40	0.66	1.65	0.44	0.33	0.11	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.95	4.40	0.29	2.35	0.59	0.15	0.15	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	8.16	1.36	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.07	3.17	0.21	2.53	0.00	0.42	0.00	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	5.83	0.00	0.00	0.00	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	1.12	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	6.90	2.84	0.00	0.41	0.81	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.21	3.88	0.78	1.75	0.39	0.00	0.00	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.07	3.03	0.30	0.91	0.46	0.15	0.46	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	10.10	2.75	0.00	0.61	0.31	0.31	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.36	3.43	0.38	1.14	0.38	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	6.21	1.62	0.27	0.00	0.27	0.54	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.69	5.10	0.81	4.29	0.70	0.70	0.23	0.12	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.89	2.54	0.88	3.09	0.22	1.11	0.00	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.06	1.42	0.20	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	4.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.49	0.79	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.00	4.56	0.20	0.60	0.20	0.79	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.12	2.13	0.18	0.00	0.00	0.18	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.29	2.56	0.00	0.79	0.20	0.79	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.09	4.51	1.81	1.20	0.60	2.11	0.30	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.45	2.81	0.65	0.54	0.32	1.62	0.32	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.34	5.06	0.51	0.51	0.51	0.51	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	8.37	2.46	0.49	0.16	0.00	0.16	0.00	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	40.50	6.42	1.60	2.21	1.20	2.01	0.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	10.25	2.51	0.10	0.30	0.30	0.50	0.00	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.41	5.74	1.21	1.21	0.91	0.30	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.41	2.73	0.17	0.66	0.58	0.25	0.17	0.08	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.55	1.71	0.17	0.17	0.00	0.00	0.00	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.68	4.93	0.99	0.33	0.33	0.99	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.37	1.49	0.32	0.32	0.00	0.32	0.00	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	7.25	2.53	0.51	0.84	0.51	0.34	0.00	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.61	0.94	0.16	0.16	0.16	0.31	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	3.49	0.87	2.61	0.00	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	37.45	6.41	2.25	3.81	1.56	1.91	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.86	3.90	0.26	3.12	0.52	1.04	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.26	5.62	2.30	4.60	1.28	1.28	1.53	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.83	1.53	0.77	0.77	0.77	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.93	3.83	1.28	1.28	1.28	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	7.13	3.71	0.00	0.57	0.29	0.29	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	26.75	5.79	0.55	1.65	0.00	0.00	1.10	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	25.12	6.16	0.91	2.51	0.91	0.23	0.68	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.50	3.17	0.20	0.99	0.20	0.00	0.00	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	24.05	5.82	0.26	1.59	0.00	0.00	0.79	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.11	6.85	1.30	0.98	0.00	0.33	0.00	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.96	1.77	0.44	1.77	0.00	0.44	0.00	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.04	2.40	0.71	0.42	0.42	0.00	0.14	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	9.11	2.46	0.37	0.86	0.12	0.00	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.45	1.61	0.00	0.81	0.27	0.00	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.45	4.46	0.00	1.61	0.50	0.50	0.50	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.72	6.64	0.42	2.63	0.83	0.69	0.42	0.14	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.47	3.05	0.20	2.24	0.61	0.00	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.68	2.28	0.23	1.37	0.91	0.00	0.46	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.39	4.48	0.75	2.74	0.62	0.87	0.62	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.48	4.15	0.87	5.25	0.22	0.22	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.18	1.48	0.59	1.48	0.00	0.30	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.19	3.50	0.16	1.27	0.48	0.79	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.54	3.35	0.45	2.01	0.45	0.45	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.69	1.61	0.00	1.01	0.00	0.40	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	13.57	3.05	0.34	1.36	0.00	0.00	0.17	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.93	2.66	1.51	2.75	0.44	0.09	0.62	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.63	2.91	0.62	0.73	0.00	0.21	0.52	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.30	1.20	0.34	0.85	0.17	0.00	0.17	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.84	2.55	0.66	0.89	0.33	0.00	0.44	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.30	2.83	0.58	1.50	0.08	0.17	0.58	0.08	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.95	3.47	1.43	0.82	0.41	0.00	1.23	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	10.32	1.03	0.00	0.21	0.00	0.00	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.22	2.54	0.46	0.58	0.23	0.00	0.23	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	16.84	3.17	1.33	1.17	0.50	0.33	0.17	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6.61	2.20	0.22	0.66	0.22	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.44	1.84	0.25	0.86	0.12	0.00	0.25	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.62	2.11	0.32	1.78	0.49	0.32	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.94	2.57	0.32	0.96	0.32	0.00	0.96	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.10	1.61	0.38	0.57	0.47	0.00	0.09	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.07	1.27	0.16	0.32	0.32	0.00	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.12	2.13	0.61	0.91	0.00	0.00	0.91	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	8.26	1.99	0.73	0.52	0.42	0.10	0.10	0.31	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	8.78	1.98	0.66	1.54	0.22	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.86	1.40	0.28	0.56	0.00	0.00	0.56	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.74	2.78	1.20	1.02	0.28	0.00	0.37	0.37	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.96	1.60	1.34	1.34	0.27	0.00	0.27	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.90	2.14	1.22	1.22	0.46	0.15	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.57	1.81	1.04	0.52	0.91	0.13	0.26	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.82	1.63	1.90	0.81	0.00	0.00	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.85	2.21	0.55	0.37	0.00	0.00	0.00	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.53	1.75	0.66	0.88	0.22	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	0.99	0.99	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.87	2.24	0.53	0.92	0.26	0.00	0.13	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.11	2.22	0.20	1.01	0.00	0.00	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.45	3.05	0.76	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4.78	1.39	0.40	0.20	0.00	0.00	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	4.93	2.31	0.15	0.46	0.15	0.00	0.00	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.34	1.84	0.00	1.02	0.00	0.00	0.00	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	6.88	0.94	0.31	0.94	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.50	1.98	0.00	0.00	0.57	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	3.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.28	2.71	0.39	0.77	0.00	0.00	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	6.42	0.00	0.00	0.00	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	3.48	0.00	3.48	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.11	4.23	0.00	0.65	1.30	0.00	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.35	2.47	0.82	1.65	0.00	0.00	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.95	3.64	1.12	1.68	0.00	0.00	0.00	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.48	3.92	0.00	0.65	0.33	0.00	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	6.71	2.52	0.00	1.68	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.77	4.77	0.00	1.59	0.32	0.00	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.17	2.72	0.00	1.02	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	6.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4.01	3.44	0.00	0.57	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.22	1.18	0.30	1.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	0.00	0.00	1.69	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.53	2.07	0.41	0.00	0.83	0.00	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.97	2.53	1.15	0.69	0.00	0.23	0.00	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	8.84	1.54	0.38	0.38	0.00	0.00	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.19	2.61	0.33	1.63	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	0.67	0.00	0.67	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	8.86	0.39	0.00	1.16	0.00	0.00	1.16	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.43	1.71	1.37	0.68	1.37	0.34	0.00	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	4.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	4.25	0.00	1.42	0.94	0.00	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.07	3.02	0.60	1.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	6.10	1.53	0.00	2.03	0.00	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	9.57	2.39	0.40	0.80	0.40	0.00	0.00	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	6.91	2.47	0.00	0.49	0.00	0.00	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	9.44	0.00	0.00	0.00	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	10.50	2.92	0.00	0.00	0.58	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	6.14	2.19	0.00	0.44	0.00	0.44	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	4.24	0.00	1.70	0.00	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	0.00	1.19	1.79	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.76	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	0.00	1.14	0.00	2.28	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	2.49	0.00	0.83	0.42	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	1.12	0.00	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.03	0.00	0.32	0.63	0.00	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	5.57	0.81	0.23	0.58	0.23	0.12	0.00	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	5.57	0.84	0.84	0.34	0.34	0.00	0.00	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.78	1.37	0.68	0.23	0.23	0.00	0.00	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	4.37	0.33	0.77	0.33	0.55	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.94	1.29	0.00	0.43	0.00	0.00	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.60	1.29	0.22	0.43	0.22	0.00	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5.60	1.12	0.62	0.75	0.37	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.15	0.86	0.34	0.00	0.00	0.00	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.77	1.28	0.32	0.00	0.32	0.00	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	2.80	0.00	1.68	0.00	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	0.00	0.00	2.60	0.00	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	5.29	0.00	13.22	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	1.41	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	0.73	0.00	0.00	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.36	1.22	0.17	0.87	0.17	0.17	0.00	0.00	0.35
Hepatocyte, donor1	11523-119I2	4.84	2.42	0.00	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	1.08	0.00	1.08	0.00	0.00	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	15.95	2.45	0.00	1.84	0.61	0.00	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.26	1.96	7.18	3.92	1.96	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	9.26	2.10	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.76	1.23	0.14	0.55	0.14	0.14	0.00	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	1.38	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	5.13	0.00	0.00	0.00	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	4.57	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	5.00	1.67	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	3.63	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	43.67	5.29	1.32	2.65	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	4.43	0.00	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	0.00	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.71	2.52	0.00	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	6.19	3.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	39.41	5.17	0.00	2.58	0.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	4.83	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	5.70	0.81	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	28.13	4.62	1.26	1.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	37.77	11.25	0.80	0.00	0.80	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	2.77	0.92	1.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	1.89	0.47	0.00	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	1.81	0.00	1.81	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	1.08	1.08	1.08	0.00	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	0.00	0.00	3.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	23.59	2.55	0.64	1.28	0.64	0.64	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	3.65	1.82	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	2.14	0.00	0.71	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	1.23	0.00	0.62	0.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	16.69	4.87	0.00	0.70	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	6.64	0.00	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	6.98	1.74	2.62	0.00	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	9.00	2.25	4.50	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	6.97	0.00	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	6.40	0.00	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	2.85	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	34.98	6.44	0.92	1.84	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	3.03	0.00	0.00	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	29.61	5.29	1.06	2.11	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	13.55	1.22	0.33	1.22	0.16	0.24	0.08	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	9.37	1.17	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.91	3.03	0.76	1.89	0.38	0.00	0.00	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	14.64	2.72	0.45	1.14	0.11	0.11	0.00	0.11	0.23
Keratocytes, donor1	11527-119I6	14.78	2.41	0.34	0.34	0.34	0.00	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	0.00	1.17	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	18.18	1.78	0.00	0.79	0.40	0.00	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	4.40	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	1.08	2.16	3.24	0.00	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.22	1.73	0.58	0.92	0.58	0.12	0.00	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	14.43	1.61	0.71	0.61	0.50	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.60	3.08	0.47	3.20	0.12	0.47	0.12	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	20.37	1.67	0.28	3.35	0.00	0.56	0.00	1.67	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.37	3.78	1.42	2.68	0.31	0.63	0.16	1.26	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	2.15	1.08	4.30	0.00	0.00	0.00	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	1.26	0.32	1.58	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.71	2.26	0.54	2.48	0.32	0.43	0.11	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.68	2.87	0.41	4.10	0.41	0.82	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.42	2.28	0.51	2.28	0.25	1.01	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.94	2.53	0.84	2.11	0.14	0.70	0.28	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	31.64	6.33	1.19	4.35	0.00	0.00	0.40	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.32	3.49	0.97	6.01	0.39	0.39	0.00	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.77	1.85	1.11	2.78	0.19	0.74	0.37	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	28.57	4.53	1.05	2.44	0.35	0.35	0.35	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.68	4.05	0.24	4.77	0.95	0.00	0.24	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.66	2.88	0.27	2.06	0.41	0.41	0.69	0.96	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.33	3.70	0.00	4.00	0.62	2.16	0.00	1.23	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	22.76	4.05	0.94	4.05	0.62	0.00	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.62	3.29	0.91	2.20	0.55	0.55	0.73	0.18	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.91	4.61	0.00	3.62	0.00	0.66	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.77	3.22	0.59	1.76	0.00	0.00	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.67	2.99	0.75	3.24	0.25	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.01	3.88	0.00	4.36	0.00	0.97	0.00	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	35.55	3.77	1.08	2.96	0.54	1.89	0.00	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.43	2.12	0.61	3.33	0.00	0.45	0.00	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	3.11	0.00	2.07	0.52	0.00	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	49.83	2.93	1.05	8.38	0.84	0.63	1.05	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.22	2.41	1.20	4.36	0.45	0.60	0.15	0.75	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.76	6.88	1.38	4.13	0.00	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.23	2.82	0.75	5.64	0.19	0.75	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.86	1.38	0.42	2.12	0.21	0.85	0.11	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	2.91	1.45	1.45	0.97	0.00	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.46	4.30	0.33	2.32	0.33	0.33	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.81	3.10	0.00	1.61	0.25	0.62	0.12	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	30.36	5.92	0.74	1.11	0.00	1.11	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.84	4.20	1.48	4.45	0.25	0.49	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.94	1.51	0.55	2.06	0.41	0.14	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.09	4.18	0.96	4.18	0.64	0.00	0.00	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.30	3.65	1.22	8.52	0.61	0.00	0.00	0.91	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.01	3.22	0.42	3.78	0.84	0.28	0.14	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.89	4.98	0.71	3.20	0.36	1.42	0.36	1.42	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.18	2.42	0.97	3.39	1.45	0.00	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.54	2.18	0.16	1.87	0.31	0.31	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.86	1.07	1.07	1.79	0.36	0.00	0.00	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.75	2.61	0.33	4.57	0.33	0.65	0.00	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.36	1.65	0.00	1.88	0.00	0.71	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.49	2.23	0.87	3.71	0.74	0.50	0.25	0.50	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	35.09	4.35	0.51	4.10	0.26	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	2.09	0.30	2.39	0.00	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	3.84	0.00	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	4.45	0.00	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	2.96	0.00	1.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	2.11	0.70	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	2.80	0.00	0.93	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	1.55	0.00	2.06	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	1.19	0.00	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.27	3.17	1.13	1.58	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.98	2.33	0.58	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6.75	0.00	0.00	0.00	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.92	3.39	1.22	1.76	0.14	0.00	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	2.05	0.51	0.00	0.51	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.59	2.12	0.35	0.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.00	2.67	0.00	0.67	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.26	4.58	0.51	1.53	1.02	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.67	2.40	0.80	0.80	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.88	2.08	0.38	1.32	0.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	3.07	0.61	0.61	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	2.45	0.82	1.63	0.00	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.16	1.67	0.62	0.42	0.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	2.24	0.56	1.96	0.28	0.00	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	2.06	1.03	4.12	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	3.77	0.29	2.03	0.29	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.57	2.69	0.00	1.20	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	1.66	0.00	1.11	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.08	1.06	0.35	0.71	0.00	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.43	2.58	0.74	1.11	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	3.45	1.15	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.89	3.07	0.38	0.77	0.77	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	2.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	4.10	0.00	0.00	0.82	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	2.71	0.45	1.36	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	1.44	0.00	0.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	2.24	0.00	1.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.12	2.97	0.00	0.37	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.32	1.72	0.43	1.29	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	4.28	0.00	1.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.99	3.00	0.00	1.33	0.00	0.00	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	1.81	1.21	1.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	3.55	0.00	1.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.62	2.75	1.03	1.03	0.00	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	2.02	0.67	1.35	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.82	1.85	0.37	1.11	0.00	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	2.33	0.00	0.00	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	3.17	0.00	2.12	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	3.60	0.40	0.80	0.40	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	5.09	0.00	2.18	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	3.07	0.00	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.81	3.95	0.99	2.96	0.49	0.00	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	1.88	0.00	0.00	0.00	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	3.02	0.00	1.51	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	3.15	0.00	0.45	1.35	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.91	4.45	0.89	0.45	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.12	2.74	0.39	1.17	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.64	5.19	1.04	1.56	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.69	4.81	0.44	1.75	1.31	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	3.35	0.00	2.80	0.56	0.56	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.34	2.21	0.88	1.77	0.44	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.74	3.47	0.00	1.16	0.39	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.76	6.08	0.51	2.03	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.86	3.84	1.44	0.00	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.27	4.77	0.40	0.40	0.00	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	4.25	0.61	1.22	0.00	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	2.08	0.00	1.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13.30	4.94	0.00	1.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.66	4.13	1.55	2.58	0.00	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	3.02	0.00	0.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.58	3.80	0.32	1.90	0.00	0.00	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.93	1.60	0.00	2.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	18.39	2.30	0.57	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	17.48	2.57	0.51	4.63	0.00	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	4.24	0.00	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.32	7.94	0.00	0.57	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.22	2.50	0.42	1.66	0.42	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	1.57	1.57	2.35	0.78	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.19	2.92	0.42	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.73	3.25	1.86	1.39	0.00	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	2.68	0.00	0.00	0.00	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	3.74	1.07	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.08	4.04	0.00	0.81	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	1.84	0.92	0.00	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	4.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.40	3.99	0.00	1.14	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	4.60	0.77	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.57	3.83	0.55	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.58	6.68	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.34	3.38	0.78	2.34	0.26	0.00	0.00	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	1.99	0.66	0.66	0.00	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	8.31	0.00	2.08	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	9.12	2.28	0.00	0.46	0.46	0.00	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	11.01	2.02	1.28	0.18	0.73	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	6.42	1.31	0.13	0.52	0.39	0.00	0.00	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	0.53	0.00	1.59	0.53	0.53	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	15.21	2.22	1.27	1.27	0.48	0.32	0.16	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	19.18	2.78	0.97	1.39	0.69	0.56	0.42	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	27.60	2.29	0.60	1.30	0.50	0.30	0.10	0.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	17.08	2.61	1.16	1.16	0.29	1.16	0.00	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	6.73	1.00	0.25	1.00	0.50	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	192.53	5.42	11.52	23.73	8.81	58.30	0.00	0.68	5.42
Mast cell, donor1	11563-120D6	56.67	5.84	3.68	2.70	0.97	1.30	1.41	1.73	0.65
Mast cell, donor2	11565-120D8	148.88	15.16	5.05	3.27	2.08	4.46	2.67	1.49	0.59
Mast cell, donor3	11566-120D9	106.48	15.76	1.13	4.05	2.25	1.80	2.70	1.58	0.68
Mast cell, donor4	11567-120E1	137.04	15.78	2.30	5.67	2.66	4.43	3.19	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	54.89	8.21	2.99	4.10	1.66	1.55	0.67	0.67	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	57.20	5.25	1.75	1.17	0.00	1.75	0.58	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	16.86	5.39	0.69	1.38	0.11	0.80	1.38	0.23	0.57
Mast cell, expanded, donor8	11941-126A6	18.41	7.20	0.33	1.67	0.50	0.00	2.34	2.18	1.51
Melanocyte - dark, donor1	11502-119F8	23.18	3.28	0.50	1.79	0.99	0.50	0.80	1.49	1.49
Melanocyte - dark, donor2	11582-120F7	10.04	1.38	0.69	1.73	0.00	0.69	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	11.88	2.61	1.16	0.51	0.36	0.22	0.22	0.22	0.22
Melanocyte - light, donor1	11274-116H5	6.82	3.29	0.71	0.47	0.00	0.00	0.71	0.00	0.24
Melanocyte - light, donor2	11351-117H1	11.60	5.46	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.87	0.00	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	6.98	2.19	0.10	0.62	0.00	0.10	0.42	0.00	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	6.45	1.88	0.54	0.27	0.00	0.00	0.54	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	10.18	2.41	0.27	0.54	0.00	0.27	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	8.68	2.73	0.12	0.00	0.12	0.00	0.25	0.00	0.12
Meningeal Cells, donor2	11573-120E7	5.28	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	11.82	3.26	0.33	1.96	0.41	0.08	0.00	0.16	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	12.83	1.43	0.86	0.86	0.29	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.82	1.41	1.01	1.61	1.31	0.30	0.30	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	2.87	0.00	1.44	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.47	1.69	0.21	0.42	0.00	0.21	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.54	1.51	0.00	0.00	0.00	0.00	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.08	1.32	0.00	0.22	0.44	0.00	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	0.73	0.00	0.73	0.00	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.14	1.02	0.00	0.61	0.20	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.59	0.69	0.14	0.00	0.28	0.42	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	9.34	1.18	0.00	0.79	0.13	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	0.59	0.00	0.59	0.30	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	0.00	0.00	0.00	0.00	0.64	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	18.08	1.42	0.35	1.42	0.35	0.35	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.51	1.25	0.31	0.63	0.63	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	0.00	0.73	1.45	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	1.06	0.80	0.00	0.00	0.00	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	8.51	2.50	1.50	0.00	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.62	1.81	0.58	0.65	0.36	0.22	0.36	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	0.00	0.00	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.56	1.97	0.49	0.74	0.25	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	3.24	1.18	1.18	0.29	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	2.79	0.31	0.31	0.00	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.98	1.04	0.21	0.21	1.04	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.76	2.50	0.50	0.75	0.00	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.72	2.79	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.72	2.64	0.20	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	1.58	0.40	0.79	0.79	0.00	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	1.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	0.76	0.00	0.38	1.14	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.58	1.27	0.42	0.00	0.42	0.21	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.24	2.38	0.30	0.00	0.89	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	1.68	0.00	3.35	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.52	2.01	0.25	1.25	0.00	0.00	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	0.95	0.48	1.66	0.71	0.24	0.24	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	1.11	1.11	0.00	0.00	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.28	1.61	1.15	1.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.36	1.89	0.00	1.47	0.42	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.53	3.67	0.61	3.26	1.02	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	3.00	0.43	3.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.78	2.45	1.11	1.33	0.67	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.52	1.53	0.22	1.75	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	1.01	0.51	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	1.66	3.31	1.66	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.28	4.08	1.09	4.08	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.41	2.65	0.29	0.59	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	3.27	1.09	3.27	3.27	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	1.92	0.00	3.84	0.96	0.48	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.41	3.20	0.00	1.60	0.80	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	1.37	1.37	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.53	2.50	0.00	1.00	1.50	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.46	2.19	0.44	1.75	0.88	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	0.00	2.21	1.10	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.92	1.28	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	1.49	0.50	1.98	0.74	0.00	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	2.78	0.70	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	1.71	0.00	0.00	0.00	0.00	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	2.19	0.00	0.44	0.88	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	1.07	0.00	0.71	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.10	1.96	0.00	0.28	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	0.42	0.42	0.42	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	0.00	1.17	0.58	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.48	2.71	0.90	1.21	0.60	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	2.09	1.25	0.83	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	3.69	1.85	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	2.28	0.57	0.57	0.00	0.57	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.64	0.97	0.41	0.55	0.83	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.37	1.55	0.78	1.55	0.26	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.58	2.14	0.43	0.86	0.43	0.00	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	1.27	0.00	0.64	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	0.53	0.53	0.27	0.27	0.00	0.27	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.18	2.10	1.20	0.00	0.00	0.30	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.78	0.42	0.28	0.14	0.28	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.37	0.64	0.64	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.17	3.10	1.11	0.44	1.11	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	1.14	0.38	0.38	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	1.42	0.85	0.00	0.28	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	1.72	0.25	0.74	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	1.30	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.94	1.47	0.29	0.29	0.00	0.00	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.96	1.15	1.15	0.00	0.29	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.13	1.65	1.24	0.00	0.00	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.91	2.08	0.89	1.19	0.00	0.00	0.00	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	1.31	0.00	0.66	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	1.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	1.78	0.20	0.59	0.00	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	4.66	0.00	0.93	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	2.25	1.13	0.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.19	1.60	0.27	0.80	0.00	0.00	0.00	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.85	0.90	0.34	0.11	0.11	0.00	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	0.00	0.00	0.00	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.76	0.37	0.37	0.37	0.37	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	0.00	0.00	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	2.67	0.53	0.00	0.53	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	5.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	0.84	0.42	0.84	0.00	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	2.72	0.00	0.00	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.81	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	4.53	1.51	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	11.42	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	0.00	9.79	0.00	3.26	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	12.55	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	5.39	1.72	0.65	0.22	0.22	0.00	0.00	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.79	2.09	0.00	0.00	1.05	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	2.67	0.67	0.67	0.00	0.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	1.67	0.00	2.09	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.36	2.85	0.38	1.90	1.90	2.47	0.19	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	4.79	0.00	1.60	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	2.72	0.68	0.68	1.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	5.51	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.16	3.77	0.84	4.19	0.42	0.84	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.90	1.63	0.46	0.93	0.93	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	3.78	0.27	2.43	0.81	0.54	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.55	4.41	0.63	2.73	1.05	0.63	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	1.99	0.99	0.50	0.50	0.99	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.74	0.27	0.27	1.62	0.27	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.88	1.36	0.45	0.45	0.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.74	2.78	0.00	1.47	0.33	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.77	3.10	0.55	1.28	0.55	0.73	0.18	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.26	2.65	0.00	2.12	0.53	1.06	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	2.40	0.00	1.80	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.55	1.64	0.33	1.64	0.66	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.41	1.63	0.33	1.14	0.98	0.81	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.29	3.88	0.18	1.23	0.35	0.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.99	2.11	0.00	1.41	2.81	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	2.76	0.92	2.30	0.00	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	2.25	0.96	1.61	0.32	0.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.86	2.76	0.69	1.38	0.69	3.45	0.00	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	2.53	2.53	0.00	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.37	2.45	0.89	0.89	0.22	0.45	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	0.85	0.85	1.27	0.42	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.73	1.90	0.00	1.90	0.71	0.47	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.88	1.29	0.00	0.43	0.43	0.43	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	0.00	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	1.33	0.00	1.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	1.80	0.45	0.45	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	1.19	0.79	1.19	0.40	0.00	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	2.79	0.00	1.86	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	1.14	0.76	0.00	1.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.43	1.30	0.00	0.33	0.33	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	2.61	0.87	1.31	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.85	0.45	0.45	2.71	0.45	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	0.88	0.00	1.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	0.66	0.66	1.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.37	2.48	0.99	0.50	0.50	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.66	1.15	0.38	0.00	0.38	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.73	2.72	0.30	0.60	0.30	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.73	1.55	0.44	1.11	0.44	0.22	0.00	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	2.03	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	1.22	0.00	0.00	0.00	0.00	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.67	0.94	0.31	0.31	0.00	0.31	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	2.42	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	1.58	0.00	0.79	0.00	0.00	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	1.13	0.00	1.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	15.40	2.36	1.37	1.74	0.87	1.24	0.12	0.00	0.00
Myoblast, donor2	11322-117D8	9.78	1.73	0.19	1.34	0.77	0.38	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	22.03	2.52	1.18	1.68	0.67	0.34	0.17	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.72	1.90	4.52	0.58	0.88	0.15	0.15	1.02	1.02
Natural Killer Cells, donor1	11230-116C6	189.74	1.54	106.71	2.46	47.97	1.54	3.69	3.08	3.38
Natural Killer Cells, donor2	11311-117C6	170.68	3.32	79.61	2.71	44.93	0.00	1.51	2.11	2.71
Natural Killer Cells, donor3	11387-118C1	157.92	2.76	69.57	2.76	34.05	0.55	1.84	4.42	5.15
Neural stem cells, donor1	11275-116H6	44.64	3.63	2.18	1.81	0.00	0.73	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	34.66	1.93	0.00	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	22.76	2.28	0.00	4.55	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	20.92	1.98	0.22	1.32	0.22	0.00	0.00	0.22	0.00
Neurons, donor3	11655-122E8	20.55	2.47	0.00	3.29	0.82	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	99.30	14.85	5.57	3.71	2.78	0.00	4.64	1.86	2.78
Neutrophils, donor2	11314-117C9	40.58	8.70	17.39	0.00	5.80	0.00	0.00	2.90	2.90
Neutrophils, donor3	11390-118C4	98.35	12.83	14.66	6.11	3.67	0.00	2.44	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	11.04	2.02	0.36	1.19	0.24	0.24	0.00	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	5.54	1.63	0.00	1.95	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.42	1.00	0.20	0.00	0.00	0.00	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	4.27	1.65	0.41	0.00	0.41	0.00	0.14	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	6.08	1.30	0.43	1.01	0.29	0.00	0.00	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	3.06	1.82	0.11	0.57	0.11	0.11	0.11	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	4.68	1.75	0.00	1.17	0.19	0.00	0.19	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	13.84	3.61	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.17	0.43	0.43	0.43	0.43	0.00	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	2.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	7.04	0.78	0.39	0.00	0.20	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	9.13	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	16.35	2.13	1.42	0.71	0.53	0.53	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	13.56	3.12	0.34	1.60	0.59	0.67	0.17	0.08	0.08
Pericytes, donor1	11491-119E6	5.90	1.11	0.22	0.22	0.11	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	6.56	2.04	0.23	0.00	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.10	1.83	0.41	0.81	0.00	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	9.72	2.15	0.79	0.68	0.23	0.00	0.23	0.11	0.34
Perineurial Cells, donor2	11579-120F4	17.94	2.02	0.64	1.10	0.46	0.46	0.28	0.09	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	99.45	4.14	13.39	0.64	10.52	0.00	0.96	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	72.23	2.45	10.53	1.22	3.18	0.00	0.49	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	89.30	2.59	23.81	1.68	15.92	0.13	1.16	1.16	1.04
Placental Epithelial Cells, donor1	11278-116H9	8.61	1.20	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	6.65	1.11	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.52	0.98	0.00	0.20	0.20	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.85	0.32	0.00	0.95	0.00	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	5.82	1.50	0.38	0.56	0.56	0.00	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.14	3.39	0.65	0.65	0.52	0.00	0.13	0.26	0.26
Preadipocyte - breast, donor2	11328-117E5	4.50	1.13	0.23	0.00	0.00	0.00	0.23	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	5.65	0.75	0.32	0.64	0.21	0.00	0.11	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	8.73	3.06	0.44	0.44	0.00	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	12.61	2.72	0.14	0.72	0.29	0.14	0.57	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	4.92	0.98	0.00	0.98	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.03	2.46	0.92	1.54	0.00	0.31	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	23.37	3.90	1.42	5.67	0.89	0.89	0.18	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	21.29	2.72	1.36	2.72	0.68	0.68	0.00	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	28.97	4.10	1.58	4.19	1.12	2.70	0.47	0.00	0.28
Preadipocyte - visceral, donor2	11357-117H7	48.78	5.06	1.84	14.27	0.92	4.14	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	18.49	2.40	0.73	0.94	0.52	1.88	0.00	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.37	1.21	0.60	0.91	0.30	0.00	0.30	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	20.58	1.62	1.49	2.44	1.22	0.68	0.41	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	7.90	1.35	0.06	0.12	0.06	0.06	0.18	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	13.55	3.08	0.34	0.80	0.11	0.34	0.11	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	12.73	1.97	1.43	2.69	0.00	1.26	0.36	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	10.22	1.67	0.21	0.42	0.52	0.31	0.31	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	3.28	0.36	0.00	0.00	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.39	3.53	0.14	1.32	0.21	0.07	0.07	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	3.55	1.01	0.00	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	9.53	2.33	0.21	0.42	0.32	0.11	0.00	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	3.40	0.68	0.00	0.68	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	31.53	4.04	0.40	0.54	0.54	1.89	0.13	0.00	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.64	2.00	0.89	3.55	0.22	1.11	0.22	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	22.63	0.67	1.33	1.33	0.67	0.00	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.50	0.88	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	0.63	1.25	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.94	0.83	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3.49	0.54	0.00	0.54	0.00	0.00	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	0.84	0.00	0.42	0.84	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.86	1.74	0.00	0.39	0.19	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	3.89	0.26	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.55	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.53	0.75	0.75	1.00	0.00	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	14.03	4.14	0.27	1.87	0.40	0.13	1.20	0.80	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	3.57	0.00	0.00	0.00	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	5.50	1.10	0.00	0.55	0.55	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	0.58	0.00	1.74	0.58	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.15	1.04	0.13	0.00	0.26	0.00	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.95	1.19	0.30	0.30	0.50	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	7.14	1.78	0.33	0.33	0.11	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	7.32	2.36	0.37	0.37	0.12	0.00	0.12	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.36	1.17	0.12	0.23	0.00	0.00	0.12	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	7.40	2.77	0.46	0.23	0.46	0.00	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.85	1.37	0.41	0.27	0.14	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.41	0.76	0.00	0.30	0.00	0.15	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.27	1.08	1.43	0.54	0.54	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.17	1.58	0.29	0.00	0.29	0.00	0.14	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4.51	1.40	0.21	0.64	0.21	0.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	5.31	1.55	0.44	0.44	0.22	0.00	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.93	1.34	0.00	0.00	0.19	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	5.31	1.40	0.19	0.37	0.19	0.09	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	8.64	0.94	0.19	0.56	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.50	0.80	0.13	0.13	0.13	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.01	1.36	0.58	0.29	0.10	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.35	2.29	0.19	0.38	0.38	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.12	1.50	0.11	0.32	0.53	0.00	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	3.92	1.96	0.00	0.28	0.28	0.00	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.15	0.51	0.17	0.85	0.17	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	1.64	0.55	0.18	0.36	0.00	0.36	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.38	0.98	0.37	0.74	0.12	0.12	0.12	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	4.84	2.01	0.40	0.13	0.27	0.00	0.00	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.78	1.18	0.47	0.00	0.47	0.00	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	8.53	1.19	0.40	0.40	0.60	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	8.42	1.40	0.47	0.47	0.47	0.00	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	1.66	1.04	0.21	0.62	0.21	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.52	1.11	0.66	0.44	0.66	0.22	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.31	1.46	0.84	0.84	0.00	0.00	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.54	1.88	0.40	0.00	0.13	0.27	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	7.83	1.36	0.51	0.68	0.34	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	7.52	2.31	0.58	1.16	0.39	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	5.85	2.06	0.17	0.34	0.17	0.17	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	6.86	1.65	0.41	0.82	0.14	0.00	0.00	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4.27	1.48	0.33	1.31	0.16	0.00	0.16	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.28	0.17	0.17	0.00	0.34	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	5.92	1.33	0.44	1.04	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	8.53	1.07	0.53	0.53	0.53	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.88	0.83	0.28	0.14	0.00	0.00	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	5.95	0.71	0.24	0.24	0.24	0.00	0.00	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.46	0.40	0.20	1.81	0.40	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.22	0.94	0.28	0.28	0.09	0.00	0.19	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	5.59	3.49	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.16	1.51	0.91	0.60	0.30	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.36	0.98	0.12	0.24	0.24	0.12	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	12.81	1.89	1.46	1.46	0.29	0.00	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.30	1.22	0.00	1.22	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	7.23	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.40	1.58	1.13	1.58	0.45	0.00	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.78	2.10	0.60	0.30	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	8.97	2.48	0.47	0.24	0.00	0.00	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.39	2.13	1.28	0.64	0.85	0.00	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.02	2.40	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	5.64	1.88	0.19	0.19	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.14	1.97	0.22	0.66	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	9.86	4.38	0.55	1.64	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	8.73	1.38	0.46	0.92	0.00	0.00	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	4.53	2.06	0.21	0.62	0.21	0.21	0.62	0.00	0.00
Sertoli Cells, donor1	11255-116F4	8.28	1.66	0.00	1.66	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	2.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.15	3.61	0.62	1.14	0.62	0.44	0.62	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	8.67	2.89	0.00	1.45	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	26.75	5.02	2.51	0.84	2.51	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	10.68	2.04	0.00	0.31	0.31	0.00	0.16	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	11.74	2.38	0.45	0.59	0.30	0.15	0.00	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	16.93	2.31	0.77	0.62	0.00	0.15	0.15	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.24	2.39	0.38	1.39	0.13	0.25	0.00	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.41	2.00	0.29	1.43	0.00	0.29	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	16.07	3.57	0.69	1.69	0.69	0.10	0.10	0.20	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.24	1.43	0.67	1.01	0.17	0.00	0.25	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	22.44	3.62	1.45	1.45	0.72	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.82	1.65	0.55	0.83	0.41	0.41	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	16.12	0.00	2.69	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.81	1.59	0.14	1.30	0.14	0.29	0.29	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	185.66	29.44	1.64	2.45	3.27	17.99	0.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.04	1.56	0.00	1.04	0.26	0.39	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	15.15	1.81	1.81	0.97	0.70	0.97	0.14	0.00	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	31.23	3.52	0.84	1.97	1.55	1.83	0.00	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	115.24	15.65	2.11	8.03	1.69	6.98	0.63	1.69	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	11.32	1.72	0.67	1.05	0.67	0.07	0.00	0.15	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.97	2.16	1.23	0.62	0.00	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.68	3.33	1.33	1.56	0.44	1.78	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	77.59	4.70	4.70	2.35	4.11	2.94	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	42.65	4.42	1.55	3.31	0.00	2.21	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	1.18	1.18	1.97	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	71.85	4.64	3.86	4.64	3.09	6.18	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	2.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.58	4.39	2.79	3.73	2.00	1.33	0.93	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.74	2.44	0.22	1.11	0.44	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.29	3.84	1.66	1.41	1.02	2.30	0.26	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.37	2.60	0.98	0.33	0.00	0.33	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.24	2.95	1.18	1.18	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	2.14	0.43	1.00	0.57	0.14	0.00	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.16	0.33	0.16	0.16	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.66	1.83	0.30	0.61	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	20.71	3.54	0.51	1.26	1.01	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	3.34	0.95	1.91	2.38	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.39	2.51	0.29	1.33	0.00	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.12	2.15	0.22	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.22	3.78	0.31	1.15	0.21	0.21	0.10	0.10	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.52	2.01	2.94	1.70	0.62	0.77	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	2.16	2.16	2.16	0.00	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.89	3.29	0.60	2.09	0.30	1.49	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.92	2.36	0.08	1.49	0.08	0.16	0.16	0.16	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.08	1.91	1.21	1.11	1.11	0.81	0.70	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.60	6.60	1.37	8.42	0.46	2.73	0.23	0.23	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	31.40	2.42	1.81	0.00	0.60	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.16	2.38	0.26	0.53	0.79	0.26	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.12	1.33	0.93	0.27	0.00	0.13	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.02	2.13	0.38	1.00	0.25	0.38	0.38	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.88	1.78	0.25	0.00	0.51	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.47	4.07	0.45	2.41	1.06	1.51	0.15	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	1.50	0.00	0.75	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	36.18	3.88	0.00	5.17	0.00	3.88	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	29.30	4.19	0.93	1.40	0.93	1.86	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.30	3.03	0.50	2.52	1.51	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	27.89	3.45	3.45	1.57	0.94	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.33	1.75	0.42	0.42	0.08	0.25	0.00	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	2.34	0.47	0.47	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.11	2.88	2.73	3.60	1.58	1.01	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	30.08	3.82	2.80	3.82	1.53	0.51	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.38	2.63	0.19	0.94	0.56	1.32	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	14.53	2.79	0.28	1.26	0.14	0.70	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	7.54	1.84	0.17	0.50	0.34	0.08	0.17	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	0.95	0.00	0.48	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.14	2.20	2.45	1.22	0.73	0.73	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.12	2.43	0.44	0.66	0.44	0.44	0.22	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.44	2.63	0.00	1.46	0.00	0.59	0.29	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.41	2.92	0.19	1.55	0.39	0.58	0.00	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.26	0.79	0.53	0.79	0.26	0.53	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.95	1.49	0.37	1.49	0.00	0.74	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	2.87	0.72	1.80	0.36	0.00	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.37	1.99	1.14	1.14	0.28	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.06	1.18	0.00	0.00	0.39	0.79	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.43	2.79	0.76	1.02	0.25	0.25	0.51	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	3.19	0.00	0.80	1.20	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	11.29	2.09	0.00	0.84	0.42	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	10.54	0.92	0.00	0.92	0.92	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	28.95	2.86	1.85	1.85	2.19	0.67	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	7.38	1.01	1.34	0.50	0.17	0.17	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	6.70	1.12	0.67	0.00	0.22	0.00	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	11.79	2.14	0.36	0.71	0.00	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	13.66	2.78	0.23	1.39	0.00	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.10	2.29	0.57	1.79	0.22	0.43	0.22	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	2.32	0.39	1.93	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	27.49	6.30	0.00	1.15	0.57	0.57	1.15	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.79	4.67	0.74	1.97	0.49	0.12	1.60	0.37	0.86
Urethra, donor2	10319-105A4	23.38	7.19	1.80	0.00	0.00	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	9.56	1.86	0.53	0.27	0.00	0.53	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	0.80	0.40	0.80	0.00	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	8.02	2.06	0.23	0.46	0.23	0.23	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	25.63	5.35	0.45	1.11	0.45	2.45	0.45	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	46.27	4.45	1.78	1.78	2.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	5.72	2.86	0.00	1.43	0.00	0.00	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	2.05	1.37	1.37	0.68	0.00	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	36.50	6.20	3.79	1.72	1.38	0.00	0.69	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.05	6.97	3.49	2.91	1.74	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	5.21	2.08	1.04	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	40.38	9.18	3.67	0.00	0.92	0.00	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	32.86	5.48	0.91	2.74	0.00	0.00	0.91	3.65	0.91
Wilms' tumor cell line:G-401	10809-111A8	4.32	0.74	0.37	0.25	0.12	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	4.40	0.00	0.00	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	9.78	0.84	0.56	0.28	0.56	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	20.67	6.20	0.00	0.00	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.41	2.04	0.76	1.02	0.00	0.00	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.72	2.09	0.23	0.23	0.23	0.00	0.23	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.63	3.21	1.42	2.49	0.59	0.12	0.24	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	13.06	1.36	1.36	1.09	0.00	0.00	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.96	0.84	0.84	0.28	0.00	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	16.28	2.11	0.21	1.69	0.42	0.00	0.00	1.06	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.22	1.09	1.09	0.82	1.36	0.27	1.36	1.36	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.74	3.08	0.00	0.44	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	8.17	1.23	0.00	0.82	0.00	0.00	0.00	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	13.59	1.55	1.94	0.00	0.39	0.00	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.36	1.10	0.18	0.37	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	22.54	3.25	0.23	0.93	0.23	0.00	0.23	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3.62	0.26	0.00	0.00	0.00	0.00	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.01	1.17	0.00	0.29	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.97	1.39	0.46	0.46	0.00	0.00	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	4.94	1.23	0.00	0.82	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.53	1.23	0.61	0.31	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	4.69	2.56	0.00	0.43	0.43	0.00	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.07	0.61	0.00	1.21	0.61	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	6.50	1.93	0.48	0.96	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1.78	0.45	0.00	0.00	0.00	0.00	0.00	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.34	1.33	0.33	1.33	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	1.86	1.86	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.34	1.51	0.00	2.26	0.00	0.00	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.34	3.93	0.44	1.74	0.00	0.44	0.44	1.31	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	0.00	0.00	3.75	1.87	0.00	1.87	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	9.18	0.94	0.24	0.24	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	31.64	5.12	0.93	2.48	0.16	0.93	2.33	1.40	1.09
adipose, donor1	10184-103D4	15.25	2.93	0.59	4.10	0.00	0.59	2.35	0.00	1.76
adipose, donor2	10185-103D5	18.65	4.87	0.81	1.22	0.41	0.00	1.22	0.00	0.00
adipose, donor3	10186-103D6	20.69	5.72	2.18	0.82	0.00	0.00	0.54	0.27	0.00
adipose, donor4	10187-103D7	10.40	17.34	0.00	0.00	0.00	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	4.26	1.58	0.32	0.16	0.32	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.80	1.07	0.00	0.67	0.27	0.00	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	56.10	4.64	1.07	5.36	1.43	2.14	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	14.37	2.09	1.85	0.93	1.16	0.70	0.00	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	8.11	2.37	0.68	0.00	0.34	0.00	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	6.78	2.36	0.59	1.18	0.00	0.59	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	69.96	7.11	4.74	1.19	1.19	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	72.39	4.46	3.24	4.06	1.01	1.42	0.41	0.20	1.01
amygdala, newborn, donor10223	10360-105E9	67.14	5.16	4.20	5.16	2.26	0.65	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	17.57	4.33	0.76	2.04	0.25	0.13	0.25	0.64	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2.87	1.32	0.66	0.88	0.44	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	22.38	1.00	0.33	1.00	0.67	0.00	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	16.48	2.75	0.20	2.35	0.00	0.59	0.00	0.98	0.39
appendix, adult	10189-103D9	34.15	8.15	1.16	3.88	0.78	0.39	0.78	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.25	0.34	0.00	1.03	0.34	0.00	0.34	0.00	0.00
artery, adult	10190-103E1	14.95	0.00	0.00	9.51	0.00	0.00	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	16.66	1.45	0.72	1.30	0.29	0.00	0.14	0.00	0.00
b cell line:RPMI1788	10427-106D4	9.81	2.23	0.45	1.19	0.45	0.15	0.45	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.70	2.22	0.55	2.77	0.55	0.28	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.24	1.29	0.79	0.89	0.20	0.10	0.10	0.20	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	9.88	0.84	0.17	1.00	0.84	0.00	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	9.51	0.56	0.00	1.12	0.00	0.00	0.00	1.12	0.56
bladder, adult, pool1	10011-101C2	27.49	3.69	0.65	3.48	0.22	0.54	0.65	0.54	0.11
blood, adult, pool1	10053-101G8	26.58	2.21	8.86	2.21	4.43	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	3.43	1.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	30.37	3.37	1.35	3.37	0.67	0.00	0.00	1.35	1.35
brain, adult, donor1	10084-102B3	53.30	3.08	3.08	3.08	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	58.46	5.68	5.79	2.67	2.23	0.78	1.89	0.33	0.45
brain, fetal, pool1	10085-102B4	48.09	8.01	2.67	5.34	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.56	1.65	0.66	0.33	0.33	0.33	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.10	2.87	0.87	2.00	0.37	0.25	0.50	0.37	0.12
breast, adult, donor1	10080-102A8	17.05	3.16	0.63	1.26	0.63	0.63	1.89	1.89	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	11.05	0.89	0.25	0.38	0.13	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.08	2.47	0.93	0.00	0.62	0.00	0.00	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	16.12	2.99	0.46	0.69	0.69	0.00	0.23	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	0.48	0.73	0.48	0.24	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	4.23	0.94	0.00	0.47	0.00	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	28.77	3.50	1.42	1.42	0.22	0.11	0.00	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	17.75	2.22	0.95	0.32	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	9.85	2.40	0.53	1.06	0.00	0.27	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	133.55	8.06	4.61	4.61	2.30	2.30	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	118.80	5.52	9.04	5.35	2.51	1.00	0.33	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	166.58	9.17	20.63	2.29	3.82	0.76	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	124.52	4.03	6.59	12.09	2.93	3.66	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	52.44	11.65	8.74	2.91	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	38.22	7.05	3.42	2.78	6.19	0.00	0.85	0.64	0.85
cerebellum, adult, pool1	10083-102B2	21.39	2.76	2.07	1.72	2.41	0.34	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	55.63	21.59	9.96	14.11	5.81	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	61.77	5.55	4.79	1.76	1.76	0.25	0.25	0.76	1.01
cerebrospinal fluid, donor2	10294-104G6	25.58	0.73	1.46	0.73	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	7.62	1.58	0.43	0.43	0.14	0.14	0.14	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	8.45	2.15	0.33	0.66	0.33	0.17	0.17	0.17	0.17
cervix, adult, pool1	10013-101C4	38.64	5.77	1.26	3.67	0.21	0.21	1.57	1.05	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.03	0.70	1.11	0.42	0.28	0.00	0.14	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.74	3.98	0.62	1.24	0.87	0.00	0.50	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	8.13	1.11	0.37	0.12	0.25	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	3.79	0.95	0.24	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	17.95	2.56	0.85	2.28	1.14	0.00	0.57	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	14.22	3.18	0.89	0.99	0.40	0.30	0.40	0.00	0.00
chorionic membrane cells, donor3	12240-129G8	11.54	3.30	1.10	1.65	1.65	0.00	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	2.02	1.01	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.60	0.77	0.38	0.38	0.00	0.19	0.38	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.36	1.27	1.48	0.63	0.21	0.84	0.21	0.42	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.61	1.28	0.00	0.77	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.93	1.69	0.24	0.73	0.48	0.24	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.86	1.63	0.00	1.63	0.00	0.20	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	16.78	4.42	0.00	0.88	0.00	0.00	0.59	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	27.63	2.61	1.04	1.04	0.52	0.26	0.26	1.04	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	9.83	1.60	0.91	1.37	0.23	0.00	0.00	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.91	2.43	0.52	1.04	0.17	0.52	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	4.76	0.73	0.37	0.18	0.00	0.00	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	30.03	1.90	0.76	1.14	0.38	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	20.23	2.38	1.19	1.19	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	38.31	4.47	0.82	1.76	0.59	0.24	1.06	0.71	0.24
colon, fetal, donor1	10070-101I7	22.25	1.85	1.24	1.85	1.85	0.00	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	385.02	13.75	18.33	18.33	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	82.44	9.77	2.55	7.22	1.27	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	31.54	2.87	1.36	2.26	0.30	0.30	0.45	0.15	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	29.75	3.53	1.41	2.54	0.42	0.14	0.14	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	111.00	4.86	2.32	7.08	0.66	3.21	0.22	0.22	0.55
cruciate ligament, donor2	10295-104G7	28.37	1.62	0.81	4.05	0.81	0.81	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	19.26	4.82	0.80	4.01	0.00	0.00	0.00	1.61	0.00
diencephalon, adult	10193-103E4	84.72	6.48	3.36	2.88	1.44	1.20	1.20	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.87	2.30	0.69	0.69	0.69	0.00	0.23	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	16.67	0.77	0.51	0.77	0.77	0.00	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.55	0.48	0.00	0.24	0.00	0.24	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	8.47	2.99	0.50	1.00	0.50	0.00	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	1.44	2.88	2.88	0.00	0.00	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	2.94	0.00	5.15	0.00	0.74	0.00	2.94	0.74
dura mater, adult, donor1	10041-101F5	27.91	1.65	1.49	1.07	0.33	0.50	0.41	1.07	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.97	2.66	4.44	2.66	3.11	0.00	2.89	1.11	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	12.75	1.29	0.43	0.57	0.14	0.00	0.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	11.72	1.85	0.00	1.23	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	30.27	1.82	1.21	5.45	2.12	1.21	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.38	3.09	0.93	2.16	0.62	0.00	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	5.25	0.00	1.31	0.00	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	23.80	3.35	0.67	0.34	0.67	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.75	6.16	1.63	5.07	1.45	1.09	0.72	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.25	1.45	0.16	0.80	0.00	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	11.12	1.33	0.33	0.44	0.22	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	10.01	1.76	0.22	0.77	0.22	0.00	0.11	0.00	0.11
epididymis, adult	10197-103E8	20.93	3.56	0.42	1.67	0.21	0.42	0.42	0.84	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	14.37	2.84	0.18	2.31	0.18	0.35	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.90	1.57	1.18	1.57	0.79	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	6.68	0.79	0.92	0.79	0.79	0.26	0.00	0.26	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.07	2.36	1.28	2.66	1.18	0.00	0.10	0.20	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	7.39	1.46	0.45	1.68	0.45	0.00	0.11	0.00	0.11
esophagus, adult, pool1	10015-101C6	21.66	3.82	0.53	1.91	0.32	0.00	1.06	0.96	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.25	1.50	0.00	0.50	0.13	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	26.56	0.00	0.00	4.83	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	12.63	6.31	0.00	0.00	0.00	0.00	0.00	2.10	4.21
eye - muscle medial, donor2	10299-104H2	26.79	1.49	1.49	1.49	0.00	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	17.20	2.29	0.00	2.29	1.15	0.00	1.15	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	1.46	0.00	0.00	1.46	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	11.95	3.31	0.51	2.54	0.00	0.51	0.25	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	25.90	2.95	1.03	1.80	0.77	0.51	0.51	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.97	2.37	0.71	0.47	0.71	1.66	0.47	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	77.03	6.76	8.16	2.63	2.53	0.47	0.28	0.38	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.71	3.60	1.20	1.50	0.30	0.00	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.01	1.10	0.82	1.37	0.09	0.18	0.00	0.09	0.00
gall bladder, adult	10198-103E9	22.69	2.66	0.72	1.21	0.48	0.24	0.24	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	98.78	5.91	37.04	2.15	17.18	0.00	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	90.01	2.61	51.17	1.49	20.54	0.00	0.37	1.49	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.93	1.48	0.84	0.42	0.84	0.00	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	9.28	0.19	0.58	0.00	0.00	0.00	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	13.94	3.28	1.15	0.33	0.82	0.00	0.00	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	21.97	4.58	0.00	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.59	2.06	0.91	1.83	0.69	0.23	0.00	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	4.02	0.80	0.23	0.11	0.00	0.00	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	18.05	2.38	0.28	1.26	0.14	0.42	0.14	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	6.98	1.75	0.50	1.00	0.25	0.00	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.81	1.90	0.53	0.74	0.32	0.21	0.11	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.74	0.84	0.28	1.12	0.56	0.14	0.00	0.14	0.42
glioblastoma cell line:T98G	10485-107A8	9.82	1.43	0.44	0.77	0.00	0.11	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	6.74	1.17	0.00	0.88	0.29	0.00	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	93.30	2.92	2.92	2.92	0.73	0.73	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	117.41	4.88	2.44	10.01	0.98	2.44	0.98	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	91.74	2.74	6.85	0.00	0.00	2.74	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	72.48	2.13	2.66	5.33	0.53	1.07	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	134.59	2.45	4.89	4.89	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.76	0.64	0.32	0.96	0.00	0.00	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	10.10	3.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.32	0.91	0.00	0.00	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	8.37	0.64	0.00	0.00	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	7.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	1.37	1.37	0.69	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	69.52	5.52	3.31	1.10	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	10.06	2.30	0.00	2.01	0.00	0.29	0.29	0.29	0.57
heart - mitral valve, adult	10205-103F7	21.53	2.39	0.00	1.49	0.30	0.60	0.30	1.49	0.30
heart - pulmonic valve, adult	10206-103F8	13.60	1.57	0.00	1.83	0.26	0.26	0.26	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	70.77	11.66	2.50	5.83	1.67	2.50	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	10.00	0.82	0.00	0.41	0.20	0.00	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	10.22	1.28	0.00	0.85	0.00	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	14.03	1.38	0.23	0.69	0.23	0.23	0.00	0.23	0.46
heart, fetal, pool1	10046-101G1	32.75	6.26	0.51	2.46	0.21	0.51	0.31	0.72	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	4.63	2.47	0.00	0.62	0.31	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	0.00	1.19	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.39	1.66	0.00	0.99	0.22	0.00	0.11	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.59	1.09	0.12	1.82	0.24	0.00	0.12	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.01	1.01	0.10	1.01	0.30	0.20	0.00	0.00	0.30
hepatoma cell line:Li-7	10484-107A7	20.91	1.22	1.00	0.89	0.44	0.11	0.22	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	10.35	1.31	0.50	0.50	0.50	0.10	0.00	0.20	0.10
hippocampus - adult, donor10196	10169-103B7	84.22	8.52	4.73	3.79	0.00	0.00	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	83.27	3.06	3.06	5.71	1.22	0.82	0.61	0.20	1.43
hippocampus, adult, donor10258	10374-105G5	62.24	4.98	6.47	0.00	1.49	0.00	0.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	81.42	8.11	3.52	6.70	2.82	0.70	0.35	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	7.93	4.27	0.00	1.83	0.00	0.00	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.91	2.75	0.59	0.39	0.39	0.00	0.20	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.32	2.54	0.25	1.27	0.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.43	8.46	0.00	2.26	0.00	0.00	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	21.17	7.49	0.52	1.81	0.00	0.00	0.77	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.94	2.28	0.38	0.38	0.00	0.00	1.52	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.99	3.50	0.29	1.46	0.58	0.00	2.04	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.59	6.25	0.65	1.72	0.22	0.00	1.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.45	6.26	0.83	1.25	0.00	0.00	0.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	29.13	3.55	2.13	2.13	0.00	0.00	0.00	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.43	3.05	0.64	1.61	0.80	0.00	0.48	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	4.71	1.35	0.67	0.00	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.23	1.41	0.00	0.16	0.47	0.00	0.16	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.44	1.97	0.00	0.98	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1.75	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	26.92	8.97	1.15	3.25	0.38	0.19	2.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.37	6.11	0.44	1.74	0.44	0.00	1.74	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	26.99	9.00	1.00	5.00	0.00	0.00	1.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.75	4.33	0.19	1.88	0.94	0.00	1.32	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.28	10.46	0.00	1.82	0.00	0.00	1.82	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.91	3.45	0.63	0.63	0.31	0.00	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.86	6.37	0.65	2.45	0.65	0.00	0.82	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.68	4.06	0.00	1.74	0.87	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	13.75	3.29	2.39	1.49	1.49	0.00	0.90	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.25	2.59	0.00	0.18	0.18	0.18	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	2.28	2.00	0.00	0.29	0.00	0.00	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6.94	0.82	0.00	0.82	1.22	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.49	3.87	0.35	1.41	0.35	0.00	1.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	4.75	0.32	1.90	0.00	0.00	0.63	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.04	6.66	0.30	2.42	0.00	0.00	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	2.59	0.52	1.03	0.00	0.00	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	1.99	0.00	1.33	0.66	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.62	3.33	0.00	0.77	0.26	0.00	0.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.99	2.81	0.51	0.26	0.51	0.26	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.17	3.03	1.51	0.76	0.00	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	17.81	5.04	1.01	2.35	0.67	0.00	0.67	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.76	2.66	0.24	0.24	0.24	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	2.67	0.00	0.00	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.80	1.95	2.44	0.49	0.49	0.00	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.73	5.50	0.31	2.75	0.00	0.00	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	13.01	0.00	6.51	0.00	0.00	13.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	15.22	6.62	0.00	1.65	0.00	0.00	0.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	20.80	2.74	0.55	1.09	0.00	0.00	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.99	5.07	1.81	1.81	0.00	0.00	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.42	1.07	0.36	1.42	0.71	0.00	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	2.39	1.19	0.00	0.00	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.57	4.60	1.63	1.63	0.27	0.27	0.81	0.00	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.13	2.96	1.08	1.35	0.27	0.00	0.54	0.27	0.27
immature langerhans cells, donor1	11904-125F5	43.59	3.87	4.60	2.91	3.87	0.24	0.24	0.48	0.00
immature langerhans cells, donor2	11905-125F6	33.27	3.96	2.38	2.38	0.00	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	92.17	6.81	11.55	2.65	3.97	0.66	0.66	0.85	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	1.95	0.65	0.00	0.00	0.00	0.65	0.00	0.33
kidney, adult, pool1	10017-101C8	9.11	1.80	0.60	0.80	0.10	0.20	0.20	0.40	0.20
kidney, fetal, pool1	10045-101F9	17.90	3.25	0.28	0.99	0.14	0.07	0.35	0.64	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	28.55	2.27	0.99	0.43	0.57	0.00	0.28	0.43	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.81	1.66	0.28	0.55	0.41	0.28	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.81	1.47	0.55	0.92	0.18	0.18	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	9.26	2.18	0.00	0.00	0.00	0.00	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	9.10	2.02	0.00	0.00	0.00	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	4.38	0.55	0.27	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	11.14	1.08	0.00	2.16	0.00	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	9.78	1.09	0.54	0.54	0.00	2.17	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	11.17	0.49	0.24	1.94	0.49	0.97	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	3.14	1.05	3.14	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.91	1.53	0.12	1.77	0.83	0.12	0.12	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	6.40	1.87	0.31	0.78	0.16	0.31	0.16	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	6.94	0.97	0.24	0.24	0.00	0.12	0.12	0.24	0.00
liver, adult, pool1	10018-101C9	11.67	1.30	0.49	1.46	0.65	0.00	1.94	0.49	0.32
liver, fetal, pool1	10086-102B5	7.53	0.94	0.00	0.00	0.00	0.00	0.00	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	46.08	3.94	1.02	3.79	0.58	0.44	0.15	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	58.69	3.51	0.74	5.35	0.74	1.29	0.18	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	41.47	4.51	2.82	2.82	0.85	0.00	0.56	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	45.85	5.89	1.68	2.94	2.10	0.42	0.42	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	5.95	0.83	0.14	0.42	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	5.52	0.00	0.00	0.69	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.82	0.53	0.13	0.40	0.13	0.00	0.13	0.00	0.00
lung, adult, pool1	10019-101D1	27.29	6.14	1.65	2.60	1.89	0.35	1.42	0.71	0.47
lung, fetal, donor1	10068-101I5	51.37	10.85	0.29	1.14	0.29	0.86	1.14	0.29	1.43
lung, right lower lobe, adult, donor1	10075-102A3	34.37	4.12	1.83	3.67	1.83	0.46	0.92	1.37	0.00
lymph node, adult, donor1	10077-102A5	28.88	3.79	0.47	2.84	0.00	0.00	1.42	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	20.16	4.60	0.88	1.97	0.88	0.00	0.44	1.75	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	8.45	1.36	0.60	1.66	0.30	0.30	0.30	0.45	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	0.00	0.85	3.40	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	23.53	2.22	0.89	0.89	0.44	0.00	0.00	1.33	0.44
mature adipocyte, donor2	12232-129F9	21.58	1.25	0.83	1.87	0.21	0.42	0.21	0.62	1.04
mature adipocyte, donor3	12233-129G1	14.70	0.95	0.24	2.13	0.71	0.47	0.71	0.00	0.24
mature adipocyte, donor4	12234-129G2	14.74	0.26	1.05	1.05	0.26	0.53	0.26	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.20	0.71	0.48	0.71	0.71	0.00	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	55.27	3.38	6.77	2.26	1.13	0.00	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	67.86	4.41	4.41	7.54	1.47	1.29	0.37	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	49.24	5.08	6.99	2.54	3.81	0.32	0.32	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	58.86	8.10	4.69	3.41	1.28	0.85	0.43	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	60.08	7.26	6.08	5.06	1.35	0.51	1.35	0.34	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	72.16	2.97	4.46	5.94	1.70	0.85	0.42	0.42	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	5.78	1.93	0.00	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	68.20	5.74	5.38	3.59	1.44	2.87	0.72	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	45.43	3.24	1.95	1.30	0.00	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	54.49	3.25	1.08	6.04	0.93	1.08	0.93	0.00	0.77
medulla oblongata, adult, pool1	10038-101F2	46.69	3.67	1.71	2.61	0.57	1.14	0.08	0.65	0.49
medulla oblongata, newborn, donor10223	10361-105F1	45.83	3.82	0.69	6.25	1.39	3.12	0.35	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	9.96	3.10	0.44	1.33	0.44	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	6.24	1.35	0.37	0.37	0.49	0.00	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	18.83	2.59	1.44	1.44	0.86	0.14	0.72	0.00	0.29
melanoma cell line:G-361	10465-106H6	8.96	2.44	0.54	0.54	1.09	0.00	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	16.82	1.63	0.54	1.45	0.18	0.00	0.18	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	12.34	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	14.26	2.33	0.52	0.52	0.26	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	27.93	3.38	0.61	1.53	0.61	1.53	0.46	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.18	2.73	0.73	1.64	0.73	0.36	0.18	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.49	0.83	0.83	0.83	0.41	0.41	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.72	1.69	0.70	0.14	0.42	1.12	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.71	1.93	0.39	0.00	0.00	0.19	0.00	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	2.08	0.00	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.50	1.37	0.17	0.69	0.17	0.86	0.34	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.57	1.61	0.00	0.81	0.23	1.27	0.00	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	28.12	1.72	0.66	1.59	0.40	1.59	0.13	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.25	4.59	1.22	2.70	0.95	3.78	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	25.75	3.84	0.28	1.99	1.00	3.98	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.48	2.63	0.33	1.98	0.66	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.03	5.26	0.55	1.66	0.28	1.52	0.14	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.76	3.84	0.70	1.75	0.35	1.40	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.72	1.22	0.00	0.20	0.00	0.61	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	2.88	0.36	1.08	0.36	0.00	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.38	1.34	0.10	0.41	0.00	0.41	0.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	1.60	1.14	1.37	0.46	0.00	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.98	1.26	0.42	0.42	0.84	1.26	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.67	2.99	0.75	2.24	0.45	0.60	0.00	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.94	2.89	0.79	0.79	1.31	0.88	0.18	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.57	1.10	0.74	1.10	0.37	0.00	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.32	1.72	2.29	0.57	0.57	0.57	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.42	2.53	0.42	0.84	0.42	0.42	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.24	3.20	0.91	0.46	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.23	1.53	0.26	0.26	0.00	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.21	0.79	0.26	1.31	0.00	0.26	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.17	2.16	0.31	1.23	0.31	0.31	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.18	0.47	0.47	0.94	0.00	0.00	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.14	2.37	1.02	0.34	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	2.36	0.39	1.18	0.00	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.73	0.46	0.93	0.93	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.27	2.60	0.29	1.15	0.00	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.16	0.67	0.22	0.22	0.00	0.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.26	3.12	0.00	1.20	0.00	0.72	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	7.33	1.47	0.00	1.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	2.01	0.67	1.34	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	3.68	0.41	1.23	0.41	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.60	2.58	0.86	2.58	0.00	1.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	0.00	0.00	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.74	0.97	0.97	0.65	0.32	0.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.26	1.07	0.53	1.60	0.00	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	0.82	0.82	2.45	1.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	2.33	0.78	1.17	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	2.10	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	0.00	0.99	1.99	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	0.59	0.00	1.78	0.59	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44	2.44	0.00	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	2.07	0.69	1.38	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	0.00	0.00	0.00	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	1.22	1.63	2.44	0.00	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	0.79	0.79	1.59	1.59	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.74	0.59	0.59	2.36	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	2.81	0.31	1.87	0.00	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	1.34	0.00	1.34	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	1.18	1.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	1.38	0.00	0.69	0.69	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	0.49	0.00	0.49	0.00	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	1.91	0.64	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.01	0.81	0.00	0.40	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	1.21	0.61	0.00	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	4.52	0.00	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	3.29	0.82	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.53	1.19	0.60	1.59	0.00	0.20	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	0.97	0.65	0.65	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	1.55	0.00	0.77	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.50	1.18	0.00	0.24	0.24	0.24	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.62	2.32	1.16	1.85	0.23	1.16	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.91	0.92	0.31	1.03	0.31	0.10	0.21	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	9.99	0.68	0.23	0.45	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	18.09	3.18	1.22	0.98	0.24	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	9.08	0.44	0.44	0.66	0.22	0.44	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	20.76	0.79	1.05	0.00	0.26	0.26	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	6.64	0.34	0.17	0.00	0.51	0.17	0.00	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	4.04	0.76	0.00	0.00	0.25	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.21	0.62	0.83	0.21	0.21	0.21	0.00	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	16.23	2.98	1.16	1.33	0.66	1.82	0.00	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	11.58	1.45	0.72	0.54	0.90	0.00	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	15.03	1.88	0.68	0.85	0.00	0.34	0.17	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	2.04	1.53	0.25	0.51	0.00	0.25	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	1.96	0.33	0.00	0.33	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	9.48	1.90	0.27	0.81	0.27	0.27	0.00	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	41.84	8.83	0.96	6.91	0.77	2.88	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	60.45	12.46	1.47	12.82	0.73	2.08	0.24	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	41.28	13.64	1.26	8.08	0.90	1.79	0.36	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.20	1.96	0.65	0.65	0.00	0.00	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	1.48	0.85	0.85	0.21	0.00	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	12.21	0.69	1.15	0.23	0.00	0.00	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.42	1.14	1.14	0.95	0.00	0.00	0.19	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	5.36	1.11	0.55	0.18	0.00	0.00	0.00	0.00	0.18
myeloma cell line:PCM6	10474-106I6	20.56	4.55	1.38	3.16	1.78	0.59	0.59	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.26	2.94	0.98	0.59	1.96	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.47	2.79	0.67	0.11	0.22	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.97	2.21	0.37	0.81	0.15	0.00	0.00	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	27.05	8.83	1.10	0.55	1.66	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	25.31	2.99	0.46	1.61	0.00	0.23	0.00	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	4.68	0.94	0.00	0.19	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	10.12	0.63	1.69	0.42	1.69	0.00	0.00	0.00	0.63
neuroblastoma cell line:NH-12	10555-107I6	6.89	2.80	0.37	0.56	0.00	0.00	0.00	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	27.76	2.85	0.95	5.46	0.71	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.01	1.74	1.43	1.74	0.48	0.16	0.16	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	6.24	1.41	0.00	0.60	0.60	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.99	1.27	1.91	1.27	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	9.05	0.80	0.27	0.80	0.00	0.27	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	89.25	29.75	74.37	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	39.74	5.92	0.00	2.37	0.34	0.51	0.51	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.02	2.40	2.40	0.80	0.80	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.37	1.28	1.92	2.56	0.32	1.60	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.31	2.10	0.00	1.58	0.00	0.00	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	123.27	7.59	11.44	1.69	2.81	0.66	0.56	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	65.93	4.12	4.12	2.06	4.12	0.00	4.12	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	79.70	3.76	2.42	5.90	1.88	1.07	0.81	1.34	1.34
occipital cortex, newborn, donor10223	10355-105E4	76.43	7.64	4.73	2.18	4.00	0.00	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	73.47	6.82	6.82	4.46	2.36	0.52	1.05	1.31	0.79
occipital lobe, fetal, donor1	10073-102A1	71.23	8.58	3.00	3.86	0.00	0.43	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	46.28	4.02	6.39	1.81	1.66	0.16	0.08	0.16	0.24
olfactory region, adult	10195-103E6	66.30	4.59	5.73	2.48	2.29	0.38	1.15	0.76	0.76
optic nerve, donor1	10277-104E7	124.06	6.00	4.00	8.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.32	2.39	1.37	1.59	0.57	0.00	0.34	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.63	1.10	0.27	0.55	0.27	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.19	1.02	0.68	1.19	0.17	0.17	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.79	1.73	0.81	0.12	0.23	0.12	0.12	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	8.82	2.35	0.88	0.29	0.29	0.00	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	22.42	0.93	0.93	0.93	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	6.79	1.48	0.00	0.42	0.21	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	25.16	3.93	0.52	2.71	0.35	0.17	0.87	0.44	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.23	1.10	0.00	0.37	0.00	0.00	0.00	0.18	0.18
pancreas, adult, donor1	10049-101G4	17.87	4.70	1.88	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.17	3.07	1.12	1.96	2.24	0.00	0.56	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	11.24	1.02	1.19	2.21	0.68	0.00	0.00	0.00	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.21	4.14	1.16	2.15	0.66	0.99	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	69.37	5.86	8.51	1.56	1.37	0.46	0.55	0.37	0.09
parietal cortex, adult, donor10258	10373-105G4	91.75	5.87	6.61	0.73	1.47	0.00	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	52.67	2.82	3.76	2.82	0.00	0.94	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	53.30	6.27	3.42	4.28	1.43	0.57	0.29	0.57	1.14
parietal lobe, adult, pool1	10034-101E7	69.53	5.20	9.08	1.94	2.38	0.53	0.44	0.09	0.70
parietal lobe, fetal, donor1	10072-101I9	64.98	8.73	1.94	5.82	0.97	0.97	1.94	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	72.15	5.98	8.60	2.62	0.37	1.50	0.75	0.00	0.00
parotid gland, adult	10199-103F1	6.78	1.23	0.00	0.00	0.00	0.00	1.23	0.62	0.00
penis, adult	10200-103F2	15.04	2.69	0.54	1.07	0.00	0.00	0.00	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.00	2.42	0.00	0.74	0.74	0.19	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.89	2.19	0.00	0.73	0.15	0.00	0.15	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	25.16	6.45	0.00	1.94	0.65	0.65	0.00	1.94	1.29
pineal gland, adult, donor10252	10160-103A7	23.10	7.70	1.18	1.78	0.59	0.00	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	23.83	8.78	1.88	2.51	1.25	1.25	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	27.32	5.06	0.00	2.02	0.00	0.00	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	20.33	3.65	0.00	2.08	0.52	0.52	0.00	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	24.69	3.40	0.85	2.55	0.00	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	12.36	3.23	0.75	1.08	0.32	0.11	0.97	0.43	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	24.37	3.97	0.79	3.58	1.19	0.26	0.40	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	14.16	2.96	0.47	1.56	0.47	0.00	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	43.21	4.05	3.36	2.15	1.98	0.52	0.26	0.26	0.34
postcentral gyrus, adult, pool1	10032-101E5	51.87	4.36	6.54	1.74	3.40	0.17	0.17	0.70	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	123.39	4.18	6.27	2.09	6.27	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	0.00	0.00	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.09	3.20	0.00	1.02	0.44	0.58	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	9.44	0.91	0.18	0.73	0.00	0.00	0.00	0.36	0.00
prostate, adult, pool1	10022-101D4	20.22	4.08	0.27	1.27	0.36	0.09	1.36	0.18	0.45
putamen, adult, donor10196	10176-103C5	199.47	8.26	16.52	7.08	3.54	1.18	0.94	0.24	0.00
putamen, adult, donor10252	10152-102I8	149.02	5.88	3.92	5.88	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	72.13	3.28	6.56	0.00	4.37	0.00	0.00	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	151.73	7.01	14.98	2.66	5.07	0.24	0.48	0.00	0.24
putamen, newborn, donor10223	10365-105F5	55.47	6.75	2.25	9.00	0.00	0.75	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	6.40	2.04	0.00	0.29	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	51.47	9.74	0.00	8.35	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.30	2.12	0.64	1.27	0.00	0.00	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.73	1.24	0.00	1.24	0.00	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	18.19	2.98	0.40	1.69	0.40	0.10	0.50	0.40	0.30
retinoblastoma cell line:Y79	10475-106I7	12.73	5.46	0.52	1.56	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	3.07	0.49	0.00	0.12	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	11.25	0.84	0.00	0.56	0.00	0.00	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	2.27	0.00	1.52	0.00	0.00	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	13.11	1.46	0.16	1.46	0.49	0.16	0.16	0.32	0.16
salivary acinar cells, donor2	11772-123I8	17.76	2.62	1.65	0.96	0.69	0.00	0.41	0.55	0.00
salivary acinar cells, donor3	11773-123I9	17.88	1.32	1.32	1.32	1.32	0.00	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	6.86	1.72	1.14	0.00	0.00	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	76.30	4.97	3.96	5.48	3.54	2.61	0.84	0.25	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.30	5.76	5.29	5.41	1.76	2.00	0.35	0.47	0.00
seminal vesicle, adult	10201-103F3	14.28	4.76	0.00	1.06	0.00	0.00	1.06	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	2.19	0.49	1.21	0.49	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.86	1.51	0.50	1.26	0.50	0.00	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	3.01	1.00	2.01	0.00	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.22	3.36	0.81	3.63	0.54	0.27	0.40	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	9.17	0.77	1.33	0.11	0.22	0.00	0.00	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.97	0.26	0.13	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	19.86	2.13	2.13	0.71	0.00	0.00	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	22.07	1.44	0.60	1.08	0.12	0.00	0.72	0.24	0.48
skeletal muscle, fetal, donor1	10066-101I3	12.06	2.01	0.00	3.02	0.00	0.00	1.01	2.01	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	19.57	1.26	0.00	3.16	1.26	0.00	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	9.01	1.33	0.00	0.33	1.33	0.33	0.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	7.88	1.26	0.95	0.32	0.00	0.00	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	18.89	2.12	0.00	0.00	0.19	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	35.44	2.64	1.48	2.64	0.66	0.49	0.00	0.66	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.15	2.25	0.00	0.64	0.32	0.00	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.54	1.53	1.53	0.87	0.87	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	29.62	4.30	0.84	0.72	0.12	0.48	0.48	0.24	0.48
small intestine, fetal, donor1	10064-101I1	16.22	2.70	0.25	1.72	0.49	0.00	0.00	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.15	1.54	0.51	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	31.79	4.14	0.26	3.36	0.00	0.26	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	4.82	0.54	0.00	0.27	0.80	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	50.47	3.21	1.15	4.59	1.15	0.69	0.69	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	73.73	4.73	3.15	4.34	0.39	1.18	1.18	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	56.04	2.77	0.00	0.00	0.69	2.08	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	50.62	4.88	3.66	4.27	1.83	0.61	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	67.96	3.21	0.92	9.18	2.30	1.84	0.46	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	4.78	1.05	0.60	0.75	0.15	0.15	0.00	0.15	0.00
spleen, adult, pool1	10025-101D7	16.52	4.74	0.88	1.32	0.66	0.00	3.19	1.98	1.21
spleen, fetal, pool1	10044-101F8	23.68	8.26	1.35	1.43	0.72	0.24	1.19	2.22	2.22
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.39	6.73	0.72	4.45	0.52	1.66	0.21	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.06	0.76	0.19	0.57	0.19	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	4.19	0.35	0.70	0.35	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	1.95	1.17	4.69	0.39	1.56	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	36.58	3.60	1.80	1.01	0.68	0.00	0.34	0.45	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.05	1.69	0.00	0.42	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	33.11	3.20	0.00	1.07	0.00	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	11.39	2.85	0.00	0.57	0.00	0.00	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	96.38	2.08	1.04	10.59	0.21	1.45	0.83	0.21	0.83
substantia nigra, adult, donor10258	10371-105G2	38.28	2.59	2.59	0.00	1.03	0.52	0.00	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	48.05	2.83	2.83	2.83	1.41	1.41	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.94	2.52	1.38	1.60	0.69	0.00	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	54.42	4.83	5.09	1.70	2.29	0.17	0.51	0.08	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	5.70	0.71	1.42	0.00	0.00	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	44.39	5.71	0.44	3.52	0.44	0.00	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	10.12	3.49	0.70	0.35	0.00	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	5.72	1.14	0.38	0.76	0.00	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	9.27	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.41	1.70	0.17	0.51	0.17	0.17	0.17	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	18.19	2.77	1.08	0.62	1.23	0.00	0.46	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	7.90	1.86	0.46	0.77	0.93	0.00	0.15	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.73	1.27	0.38	0.13	0.51	0.00	0.25	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.54	1.51	0.00	0.00	0.00	0.00	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.71	0.98	0.65	0.22	0.33	0.00	0.00	0.22	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.77	3.58	0.65	0.65	0.00	0.00	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	24.27	3.76	1.18	2.36	1.50	0.11	6.23	0.64	0.64
testis, adult, pool2	10096-102C6	9.47	1.80	2.71	1.35	1.80	0.00	0.45	0.90	0.90
thalamus - adult, donor10196	10168-103B6	89.42	2.21	5.52	5.52	1.10	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	118.46	4.69	3.59	12.19	0.78	1.56	0.94	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	81.60	4.62	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	44.30	2.80	3.13	2.80	1.98	0.82	0.49	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	15.53	4.60	2.30	4.03	0.00	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	18.23	2.00	0.25	1.75	0.00	0.00	0.00	0.00	0.25
throat, fetal, donor1	10061-101H7	17.06	3.96	0.00	3.66	0.00	0.00	0.61	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	9.94	1.99	0.60	0.00	0.20	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	94.15	7.85	4.57	6.66	2.09	0.20	3.98	0.20	0.00
thymus, fetal, pool1	10043-101F7	83.33	6.65	4.78	4.78	1.25	0.21	0.83	0.52	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.03	3.46	0.27	1.20	0.13	0.53	0.27	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	7.68	1.12	0.56	0.14	0.42	0.00	0.00	0.00	0.14
thyroid, adult, pool1	10028-101E1	11.76	2.71	0.37	0.75	0.28	0.28	0.37	0.65	0.19
thyroid, fetal, donor1	10060-101H6	21.09	3.16	0.00	2.37	0.00	0.00	0.26	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	3.08	0.00	0.00	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	14.65	2.33	0.93	1.40	0.93	0.47	0.23	0.70	0.23
tongue, fetal, donor1	10059-101H5	19.31	1.18	0.00	0.79	0.00	0.39	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	32.36	5.71	1.50	1.80	0.40	0.10	0.10	0.50	0.30
trachea, adult, pool1	10029-101E2	17.67	3.27	0.82	1.72	0.25	0.16	0.90	0.49	0.74
trachea, fetal, donor1	10058-101H4	21.54	3.85	0.38	1.92	0.77	0.00	0.38	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	22.32	3.54	0.35	1.06	1.06	0.71	0.00	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	12.56	2.03	0.61	0.81	0.71	0.00	0.00	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	12.69	2.19	0.94	1.10	0.78	0.00	0.47	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	19.03	0.00	0.00	1.90	3.81	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.02	2.54	0.42	0.59	0.08	0.00	0.17	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	10.43	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	62.62	7.34	0.85	1.19	0.34	1.02	0.68	0.34	1.19
uterus, fetal, donor1	10055-101H1	26.11	6.66	0.51	3.58	0.00	0.51	0.00	0.00	0.51
vagina, adult	10204-103F6	11.63	3.23	0.65	3.88	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	32.22	6.36	1.53	1.97	0.00	0.22	1.53	1.32	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.01	1.87	0.00	1.60	1.07	0.00	0.00	0.00	0.27